<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">S Afr J Bot</journal-id><journal-id journal-id-type="iso-abbrev">S Afr J Bot</journal-id><journal-title-group><journal-title>South African Journal of Botany</journal-title></journal-title-group><issn pub-type="ppub">0254-6299</issn><issn pub-type="epub">0254-6299</issn><publisher><publisher-name>SAAB. Published by Elsevier B.V.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7493762</article-id><article-id pub-id-type="pii">S0254-6299(20)31038-3</article-id><article-id pub-id-type="doi">10.1016/j.sajb.2020.08.020</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The potential role of sesquiterpene lactones isolated from medicinal plants in the treatment of the metabolic syndrome &#x02013; A review</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name><surname>Salazar-G&#x000f3;mez</surname><given-names>Anuar</given-names></name><xref rid="aff0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0002"><name><surname>Ontiveros-Rodr&#x000ed;guez</surname><given-names>Julio C.</given-names></name><xref rid="aff0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au0003"><name><surname>Pablo-P&#x000e9;rez</surname><given-names>Saudy S.</given-names></name><xref rid="aff0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0004"><name><surname>Vargas-D&#x000ed;az</surname><given-names>M. Elena</given-names></name><xref rid="aff0003" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0005"><name><surname>Gardu&#x000f1;o-Siciliano</surname><given-names>Leticia</given-names></name><xref rid="aff0001" ref-type="aff">a</xref><xref rid="cor0001" ref-type="corresp">&#x0204e;</xref></contrib><aff id="aff0001"><label>a</label>Departamento de Farmacia, Escuela Nacional de Ciencias Biol&#x000f3;gicas, Instituto Polit&#x000e9;cnico Nacional, Av. Wilfrido Massieu y M. Stampa, Col. Planetario Lindavista, 77380 Ciudad de M&#x000e9;xico, Mexico</aff><aff id="aff0002"><label>b</label>CONACYT &#x02013; Universidad Michoacana de San Nicol&#x000e1;s de Hidalgo, Edificio B-1, Ciudad Universitaria, 58030 Morelia, Michoac&#x000e1;n, Mexico</aff><aff id="aff0003"><label>c</label>Departamento de Qu&#x000ed;mica Org&#x000e1;nica, Escuela Nacional de Ciencias Biol&#x000f3;gicas, Instituto Polit&#x000e9;cnico Nacional, Prolongaci&#x000f3;n de Carpio y Plan de Ayala, 11340 Ciudad de M&#x000e9;xico, Mexico</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#x0204e;</label>Corresponding author.</corresp></author-notes><pub-date pub-type="pmc-release"><day>16</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>12</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>16</day><month>9</month><year>2020</year></pub-date><volume>135</volume><fpage>240</fpage><lpage>251</lpage><history><date date-type="received"><day>5</day><month>9</month><year>2018</year></date><date date-type="rev-recd"><day>1</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 SAAB. Published by Elsevier B.V. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>SAAB</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0001"><title>Highlights</title><p><list list-type="simple" id="celist0001"><list-item id="celistitem0001"><label>&#x02022;</label><p id="para0001">Definition and pathogenesis of metabolic syndrome is briefly described.</p></list-item><list-item id="celistitem0002"><label>&#x02022;</label><p id="para0002">Sesquiterpene lactones isolated from medicinal plants used in traditional medicine.</p></list-item><list-item id="celistitem0003"><label>&#x02022;</label><p id="para0003">
<italic>In vivo</italic> and <italic>in vitro</italic> biological activities of sesquiterpene lactones are considered.</p></list-item><list-item id="celistitem0004"><label>&#x02022;</label><p id="para0004">Chemical and biological properties of natural sesquiterpene lactones are documented.</p></list-item></list></p></abstract><abstract id="abs0002"><p>Metabolic syndrome comprises a cluster of metabolic disorders related to the development of cardiovascular disease and type 2 diabetes mellitus. In latter years, plant secondary metabolites have become of special interest because of their potential role in preventing and managing metabolic syndrome. Sesquiterpene lactones constitute a large and diverse group of biologically active compounds widely distributed in several medicinal plants used for the treatment of metabolic disorders. The structural diversity and the broad spectrum of biological activities of these compounds drew significant interests in the pharmacological applications. This review describes selected sesquiterpene lactones that have been experimentally validated for their biological activities related to risk factors of metabolic syndrome, together with their mechanisms of action. The potential beneficial effects of sesquiterpene lactones discussed in this review demonstrate that these substances represent remarkable compounds with a diversity of molecular structure and high biological activity, providing new insights into the possible role in metabolic syndrome management.</p></abstract><kwd-group id="keys0001"><title>Keywords</title><kwd>Sesquiterpene lactones</kwd><kwd>Medicinal plants</kwd><kwd>Metabolic syndrome</kwd><kwd>Hypoglycemic</kwd><kwd>Hypolipidemic</kwd><kwd>Antidiabetic</kwd></kwd-group><kwd-group id="keys0002"><title>Abbreviations</title><kwd>ACE, angiotensin I-converting enzyme</kwd><kwd>AMPK, activated protein kinase</kwd><kwd>APOC3, apolipoprotein C3</kwd><kwd>AT, adipose tissue</kwd><kwd>CAT, catalase</kwd><kwd>COX-2, cyclooxygenase 2</kwd><kwd>CVD, cardiovascular disease</kwd><kwd>FFA, free fatty acids</kwd><kwd>FN, fibronectin</kwd><kwd>G6Pase, glucose-6-phosphatase</kwd><kwd>GK, glucokinase</kwd><kwd>GPx, glutathione peroxidase</kwd><kwd>GSH, reduced glutathione</kwd><kwd>HDL-C, high-density lipoproteins-cholesterol</kwd><kwd>IFN-&#x003b3;, interferon gamma</kwd><kwd>IL-1&#x003b2;, interleukin 1 beta</kwd><kwd>IL-6, interleukin 6</kwd><kwd>iNOS, inducible nitric oxide synthase</kwd><kwd>IR, insulin resistance</kwd><kwd>JNK, c-Jun N-terminal kinases</kwd><kwd>LDL-C, low-density lipoprotein-cholesterol</kwd><kwd>LPS, lipopolysaccharide</kwd><kwd>MAPK, mitogen-activated protein kinases</kwd><kwd>MCP-1, monocyte chemoattractant protein 1</kwd><kwd>MetS, metabolic syndrome</kwd><kwd>NF-&#x003ba;B, nuclear factor kappa B</kwd><kwd>NO, nitric oxide</kwd><kwd>ROS, reactive oxygen species</kwd><kwd>SLns, sesquiterpene lactones</kwd><kwd>SOD, superoxide dismutase</kwd><kwd>STAT1, signal transducer and activator of transcription 1</kwd><kwd>STZ, streptozotocin</kwd><kwd>T2DM, type 2 diabetes mellitus</kwd><kwd>TBARS, thiobarbituric acid reactive substances</kwd><kwd>TC, total cholesterol</kwd><kwd>TG, triglycerides</kwd><kwd>TGF-&#x003b2;1, transforming growth factor beta</kwd><kwd>TLRs, Toll-like receptor</kwd><kwd>TNF-&#x003b1;, tumor necrosis factor alpha</kwd><kwd>VLDL, very-low-density lipoprotein</kwd></kwd-group></article-meta><notes><p id="misc0001">Edited by AM Viljoen</p></notes></front><body><sec id="sec0001"><label>1</label><title>Introduction</title><p id="para0005">Metabolic syndrome (MetS) refers to a cluster of risk factors related to the development of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) (<xref rid="bib0004" ref-type="bibr">Alberti&#x000a0;et&#x000a0;al., 2009</xref>). This pathological condition represents a public health concern in most nations due to its association with mortality caused by the cardiovascular and metabolic complications (<xref rid="bib0064" ref-type="bibr">Ju&#x000a0;et&#x000a0;al., 2017</xref>). Indeed, MetS is recognized as a risk factor that influences progression and prognosis of coronavirus disease 2019, the infectious disease caused by the most recently discovered coronavirus SARS-CoV-2 (<xref rid="bib0029" ref-type="bibr">Costa&#x000a0;et&#x000a0;al., 2020</xref>). Lifestyle modifications remain the primary component of MetS&#x000b4;s risk factors reduction and pharmacological therapies are indicated in special situations to improving more than one factor (<xref rid="bib0074" ref-type="bibr">Larsen&#x000a0;et&#x000a0;al., 2018</xref>). In latter years, secondary plant metabolites have become of special interest in the scientific community because of their potential role in preventing and managing MetS (<xref rid="bib0028" ref-type="bibr">Cicero&#x000a0;and Colletti,&#x000a0;2016</xref>; <xref rid="bib0046" ref-type="bibr">Francini-Pesenti&#x000a0;et&#x000a0;al., 2019</xref>). Many compounds, such as sesquiterpene lactones (SLns), have been isolated from medicinal plants and their hypoglycemic, anti-inflammatory, and antioxidative properties coupled with their capacity to modulate key cellular functions have been confirmed by <italic>in vitro</italic> and <italic>in vivo</italic> methods (<xref rid="bib0021" ref-type="bibr">Chadwick&#x000a0;et&#x000a0;al., 2013</xref>; <xref rid="bib0024" ref-type="bibr">Chaturvedi&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0005" ref-type="bibr">Alonso&#x000a0;et&#x000a0;al., 2018</xref>). Despite these effects are linked to the pathogenesis of MetS, the role of these compounds to avoid its progression is not well documented compared to many other compounds such as polyphenols into which a great deal of research has been conducted. Therefore, in order to provide relevant information regarding the potential benefits of SLns in preventing and managing MetS, this review addresses plant-derived SLns that are potentially responsible for the positive effect in improving risk factors associated with MetS.</p></sec><sec id="sec0002"><label>2</label><title>Search strategy</title><p id="para0006">An electronic literature search was conducted on SLns with hypoglycemic and/or hypolipidemic effects and isolated from plants used in traditional medicine for the same purposes. The search was done in databases of Google Scholar, Science Direct, and SciFinder until June 2020 using the keyword sesquiterpene lactones and following terms: metabolic syndrome, hypoglycemic, hypolipidemic, antidiabetic, antihypertensive, and medicinal plants. Additional information was identified from references located in the retrieved articles. Although many SLns were screened in some of the studies, only those considered active by the authors are included in this review. The plants included in this review were selected based on their ethnomedicinal records. For each species, the currently accepted name in the online &#x0201c;The Plant List&#x0201d; database has been checked and the reported name has been replaced with the current one. Compound class, plant source, biological activity and important aspects related with MetS are summarized in the <xref rid="tbl0001" ref-type="table">Table&#x000a0;1</xref>
.<table-wrap position="float" id="tbl0001"><label>Table 1</label><caption><p>Sesquiterpene lactones with potential positive effects on MetS, biological effects and mechanisms implicated (structures illustrated in <xref rid="fig0001" ref-type="fig">Figs.&#x000a0;1</xref> and <xref rid="fig0002" ref-type="fig">2</xref>).</p></caption><alt-text id="alt0003">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top">No.</th><th valign="top">Compound</th><th valign="top">Class</th><th valign="top">Plant source</th><th valign="top">Biological effects</th><th valign="top">Mechanisms implicated</th><th valign="top">Refs.</th></tr></thead><tbody><tr><td valign="top"><bold>1</bold></td><td valign="top">Enhydrin</td><td valign="top">Melampolide</td><td valign="top"><italic>Smallanthus sonchifolius</italic></td><td valign="top">Hypoglycemic (<italic>in vivo</italic>)</td><td valign="top">Post-prandial glucose levels (&#x02193;) Inhibition of &#x003b1;-glucosidase</td><td valign="top"><xref rid="bib0047" ref-type="bibr">Genta&#x000a0;et&#x000a0;al., 2010</xref>; <xref rid="bib0112" ref-type="bibr">Serra-Barcellona&#x000a0;et&#x000a0;al., 2017</xref></td></tr><tr><td valign="top"><bold>2</bold></td><td valign="top">Polymatin A</td><td valign="top">Melampolide</td><td valign="top"><italic>Smallanthus macroscyphus</italic></td><td valign="top">Hypoglycemic (<italic>in vivo</italic>)</td><td valign="top">Post-prandial glucose levels (&#x02193;)</td><td valign="top"><xref rid="bib0111" ref-type="bibr">Serra-Barcellona&#x000a0;et&#x000a0;al., 2014</xref></td></tr><tr><td valign="top"><bold>3</bold></td><td valign="top">20-dehydroeucannabinolide</td><td valign="top">Heliangolide</td><td valign="top"><italic>Helianthus annuus</italic></td><td valign="top">Antidiabetic (<italic>in vivo</italic>) Antioxidant (<italic>in vitro</italic>)</td><td valign="top">Fasting blood glucose level (&#x02193;) DPPH radical and NO scavenging activities</td><td valign="top"><xref rid="bib0093" ref-type="bibr">Onoja&#x000a0;et&#x000a0;al., 2020</xref></td></tr><tr><td valign="top"><bold>4</bold></td><td valign="top">Eremanthin</td><td valign="top">Guaianolide</td><td valign="top"><italic>Costus speciosus</italic></td><td valign="top">Hypoglycemic, and hypolipidemic (<italic>in vivo</italic>) Antioxidant (<italic>in vivo</italic>)</td><td valign="top">Blood glucose levels (&#x02193;), HbA1c (&#x02193;), plasma insulin (&#x02191;), tissue glycogen (&#x02191;) TC, TG and LDL-C (&#x02193;); HDL-C (&#x02191;) TBARS levels (&#x02193;), GSH (&#x02191;), SOD, CAT and GPx (&#x02191;) in brain, liver, heart, kidney, and pancreas</td><td valign="top"><xref rid="bib0039" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2009a</xref>, <xref rid="bib0040" ref-type="bibr">2009b</xref>, <xref rid="bib0038" ref-type="bibr">2010</xref></td></tr><tr><td valign="top"><bold>5</bold></td><td valign="top">Costunolide</td><td valign="top">Germacrolide</td><td valign="top"><italic>Costus speciosus</italic></td><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>6</bold></td><td valign="top">Alantolactone</td><td valign="top">Eudesmanolide</td><td valign="top"><italic>Inula helenium</italic></td><td valign="top">Antiinflammatory-associated to glucose intolerance and IR (<italic>in vitro</italic>) Antiinflamatory- obesity-induced IR (<italic>in vitro</italic>) Attenuates lipid accumulation (<italic>in vitro</italic>) Antiinflamatory- associated to diabetic nephropathy (<italic>in vivo</italic>)</td><td valign="top">STAT3 inhibitor. Inhibition of the TLR4 gene expression. Inhibition of TLR4-JNK signaling. IL-6 and MCP-1 (&#x02193;). APOC3 expression at both mRNA and protein levels (&#x02193;) TNF-&#x003b1; and IL-6 (&#x02193;) in diabetic kidney. Serum creatinine and urea nitrogen levels (&#x02193;).</td><td valign="top"><xref rid="bib0067" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2017a</xref>, <xref rid="bib0068" ref-type="bibr">2017b</xref>; <xref rid="bib0133" ref-type="bibr">Yang&#x000a0;et&#x000a0;al., 2018</xref>; <xref rid="bib0142" ref-type="bibr">Zhu&#x000a0;et&#x000a0;al., 2020</xref></td></tr><tr><td valign="top"><bold>7</bold></td><td valign="top">Tirotundin</td><td valign="top">3,10-epoxygermacranolide</td><td valign="top"><italic>Tithonia diversifolia</italic></td><td valign="top">Antidiabetic (<italic>in vitro</italic>)</td><td valign="top">Dual PPAR&#x003b1;/&#x003b3; agonists</td><td valign="top"><xref rid="bib0079" ref-type="bibr">Lin,&#x000a0;2012</xref></td></tr><tr><td valign="top"><bold>8</bold></td><td valign="top">Tagitinin A</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>9</bold></td><td valign="top">Tagitinin G</td><td/><td/><td valign="top">Anti-hyperglycemic (<italic>in vitro</italic>)</td><td valign="top">Glucose uptake in 3T3-L1 adipocytes (&#x02191;).</td><td valign="top"><xref rid="bib0139" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2012</xref></td></tr><tr><td valign="top"><bold>10</bold></td><td valign="top">Tagitinin I</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>11</bold></td><td valign="top">1&#x003b2;-hydroxydiversifolin-3-O-methyl ether</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>12</bold></td><td valign="top">1&#x003b2;-hydroxytirotundin-3-O-methyl ether</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>13</bold></td><td valign="top">Micheliolide</td><td valign="top">Guaianolide</td><td valign="top"><italic>Magnolia compressa</italic></td><td valign="top">Anti-inflammatory- associated to diabetic nephropathy (<italic>in vitro</italic>)<break/>Anti-hepatic steatosis (<italic>in vivo</italic> and <italic>in vitro</italic>)</td><td valign="top">Suppressed the glucose-stimulated degradation of I&#x003ba;B&#x003b1; and the subsequent activation of NF-&#x003ba;B in rat glomerular mesangial cells.<break/>MCP-1, TGF-&#x003b2;1 and FN (&#x02193;)<break/>PPAR-&#x003b3; expression (&#x02191;)<break/>AMPK/mTOR signaling pathway (&#x02191;)<break/>NF-&#x0043a;B signaling pathway (&#x02193;)</td><td valign="top"><xref rid="bib0061" ref-type="bibr">Jia&#x000a0;et&#x000a0;al., 2013</xref>;<break/><xref rid="bib0141" ref-type="bibr">Zhong&#x000a0;et&#x000a0;al., 2018</xref></td></tr><tr><td valign="top"><bold>14</bold></td><td valign="top">Byrsonine A</td><td valign="top">Guaianolide dimer</td><td valign="top"><italic>Byrsonima crassifolia</italic></td><td valign="top">Hypoglycemic, hypolipidemic and antioxidant (<italic>in vivo</italic>)</td><td valign="top">Blood glucose levels (&#x02193;), serum insulin and pancreatic insulin levels (&#x02191;)<break/>G6Pase activity (&#x02193;) and GK activity (&#x02191;)<break/>TC, TG, LDL-C and VLDL (&#x02193;); HDL-C (&#x02191;)<break/>TBARS levels (&#x02193;), SOD, CAT and GPx (&#x02191;) in liver, kidneys, and pancreas<break/>TNF-&#x003b1; levels (&#x02193;).</td><td valign="top"><xref rid="bib0051" ref-type="bibr">Guti&#x000e9;rrez&#x000a0;and Ramirez,&#x000a0;2016</xref></td></tr><tr><td valign="top"><bold>15</bold></td><td valign="top">Byrsonine B</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>16</bold></td><td valign="top">Lactucain C</td><td valign="top">Guaianolide dimer</td><td valign="top"><italic>Lactuca indica</italic></td><td valign="top">Antidiabetic (<italic>in vivo</italic>)</td><td valign="top">Blood glucose levels (&#x02193;)</td><td valign="top"><xref rid="bib0058" ref-type="bibr">Hou&#x000a0;et&#x000a0;al., 2003</xref></td></tr><tr><td valign="top"><bold>17</bold></td><td valign="top">8-deoxylactucin</td><td valign="top">Guaianolide</td><td valign="top"><italic>Cichorium intybus</italic></td><td valign="top">Anti-inflammatory</td><td valign="top">Inhibition of NF-kB activation.<break/>COX-2 inhibition.</td><td valign="top"><xref rid="bib0020" ref-type="bibr">Cavin&#x000a0;et&#x000a0;al., 2005</xref></td></tr><tr><td valign="top"><bold>18</bold></td><td valign="top">Artemisinin</td><td valign="top">Cadinanolide</td><td valign="top"><italic>Artemisia annua</italic></td><td valign="top">Vascular protection (<italic>in vivo</italic>)<break/>Antidiabetic (<italic>in vivo</italic>)</td><td valign="top">MCP-1, IFN-&#x003b3;, IL-6 and TNF-&#x003b1; (&#x02193;)<break/>Inhibition of atherosclerotic plaque formation<break/>Promote the conversion of pancreatic glucagon-producing &#x003b1; cells to insulin-secreting &#x003b2; cells</td><td valign="top"><xref rid="bib0017" ref-type="bibr">Cao&#x000a0;et&#x000a0;al., 2020</xref>;<break/><xref rid="bib0076" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2017</xref></td></tr><tr><td valign="top"><bold>19</bold></td><td valign="top">Scoporanolide</td><td valign="top">Guaianolide</td><td valign="top"><italic>Artemisia scoparia</italic></td><td valign="top">Antihypertensive (<italic>in vivo</italic>)</td><td valign="top">Inhibition of plasma ACE activity</td><td valign="top"><xref rid="bib0025" ref-type="bibr">Cho&#x000a0;et&#x000a0;al., 2016</xref></td></tr><tr><td valign="top"><bold>20</bold></td><td valign="top">Estafiatin</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top"><bold>21</bold></td><td valign="top">Cumambrin A</td><td valign="top">Guaianolide</td><td valign="top"><italic>Chrysanthemum boreale</italic></td><td valign="top">Antihypertensive (<italic>in vivo</italic>)<break/>Vasorelaxant (<italic>ex vivo</italic>)</td><td valign="top">Normalization of blood pressure</td><td valign="top"><xref rid="bib0056" ref-type="bibr">Hong&#x000a0;et&#x000a0;al., 1999</xref>, <xref rid="bib0057" ref-type="bibr">2005</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Reduction (&#x02193;); increment (&#x02191;); thiobarbituric acid reactive substances (TBARS); reduced glutathione (GSH); superoxide dismutase (SOD); catalase (CAT); glutathione peroxidase (GPx); insulin resistance (IR); Toll-like receptor 4 (TLR4); c-Jun N-terminal kinases (JNK); interleukin 6 (IL-6); monocyte chemoattractant protein 1 (MCP-1); Apolipoprotein C3 (APOC3); AMP-activated protein kinase (AMPK); peroxisome proliferator-activated receptors &#x003b1; and &#x003b3; (PPAR&#x003b1;/&#x003b3;); nuclear factor kappa B (NF-&#x003ba;B); transforming growth factor beta (TGF-&#x003b2;1); fibronectin (FN); glucose-6-phosphatase (G6Pase); glucokinase (GK); cyclooxygenase 2 (COX-2); interferon-gamma (IFN-&#x003b3;); tumor necrosis factor &#x003b1; (TNF-&#x003b1;); angiotensin I-converting enzyme (ACE).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec0003"><label>3</label><title>Metabolic syndrome</title><p id="para0007">MetS is defined as a cluster of risk factors such as raised blood pressure, atherogenic dyslipidemia, raised fasting glucose, and central obesity, related to the development of CVD and T2DM (<xref rid="bib0004" ref-type="bibr">Alberti&#x000a0;et&#x000a0;al., 2009</xref>). Since the World Health Organization (WHO) reported the first formalized definition of the MetS, the diagnostic criteria have been sequentially developed by several public health organizations (<xref rid="bib0041" ref-type="bibr">Engin,&#x000a0;2017</xref>). Nowadays, the most recognized criterion for the clinical diagnosis of MetS (<xref rid="bib0004" ref-type="bibr">Alberti&#x000a0;et&#x000a0;al., 2009</xref>) is based on identifying at least three of the following risk factors: (1) elevated waist circumference (population and country-specific definitions determined by local organizations); (2) triglycerides (TG) &#x02265; 150&#x000a0;mg/Dl (&#x0003c;1.0&#x000a0;mmol/L) or on drug treatment for elevated triglycerides; (3) high-density lipoproteins-cholesterol (HDL-C) &#x0003c;40&#x000a0;mg/dL (&#x0003c;1.0&#x000a0;mmol/L) in men or &#x0003c;50&#x000a0;mg/dL (&#x0003c;1.3&#x000a0;mmol/L) in women or on drug treatment for reduced HDL-C; (4) blood pressure &#x02265;130/85&#x000a0;&#x000a0;mmHg or on antihypertensive medication treatment, and/or a history of hypertension; and (5) fasting glucose &#x0003e;100&#x000a0;mg/dL (&#x0003e;5.6&#x000a0;mmol/L) or on drug treatment for elevated glucose.</p></sec><sec id="sec0004"><label>4</label><title>Pathogenesis of MetS</title><p id="para0008">The mechanisms underlying pathogenesis of MetS have not been completely explored, but obesity-induced adipocyte dysfunction and inflammation is associated with the progression of insulin resistance and metabolic disorders (<xref rid="bib0070" ref-type="bibr">Kl&#x000f6;ting&#x000a0;and Bl&#x000fc;her,&#x000a0;2014</xref>). Body fat mass accumulation in obesity depends on different factors including the relationship of energy intake to energy expenditure and body energy storage (<xref rid="bib0048" ref-type="bibr">Gomez-Hernandez&#x000a0;et&#x000a0;al., 2016</xref>). Adipose tissue (AT) plays an important role as an energy storage organ, as well as an endocrine organ produces adipokines such as leptin, adiponectin, monocyte chemoattractant protein 1 (MCP1), tumor necrosis factor alpha (TNF-&#x003b1;) and interleukin 6 (IL-6), which circulate and regulate systemic metabolism and inflammation. The cell type composition of AT includes adipocytes, fibroblasts, macrophages, stromal cells, monocytes and preadipocytes (<xref rid="bib0101" ref-type="bibr">R&#x000e0;fols,&#x000a0;2014</xref>). On further AT expansion, hypertrophy of adipocytes and increased secretion of macrophage chemoattractants occurs, including the secretion of MCP-1, which recruits additional macrophages. These actions in turn result in local inflammatory state, enhanced basal lipolysis, increasing the leakage of free fatty acids (FFA) and a dysregulated secretion of several pro-inflammatory adipokines (<xref rid="bib0081" ref-type="bibr">Longo&#x000a0;et&#x000a0;al., 2019</xref>; <xref rid="bib0132" ref-type="bibr">Xu&#x000a0;et&#x000a0;al., 2019</xref>). Subsequently, these adverse signals reach metabolic tissues (<italic>e.g.</italic> liver, pancreatic islets, and skeletal muscle) and modify inflammatory responses as well as glucose and lipid metabolism, thereby contributing to a global metabolic effect of insulin resistance.</p><p id="para0009">Chronic low-grade inflammation in obesity results from the activation of various inflammatory mechanisms through nuclear factor kappa B (NF-&#x003ba;B) and c-Jun N-terminal kinases (JNK) pathways. These pathways represent important modulators of cytokine gene expression downstream of Toll-like receptors (TLRs) in insulin target cells (<xref rid="bib0019" ref-type="bibr">Catrysse&#x000a0;and van Loo,&#x000a0;2017</xref>; <xref rid="bib0104" ref-type="bibr">Rogero&#x000a0;and Calder,&#x000a0;2018</xref>). NF-&#x003ba;B is an important transcription factor involved in different processes of the immune and inflammatory responses. It is composed of p50 and p65 subunits and is found in the cytoplasm in complex with inhibitory proteins of the I&#x003ba;B family. Cytokines and lipopolysaccharide (LPS) can stimulate cell surface receptors including Toll-like receptor (TLR4) to initiate a signaling cascade that converge on the activation of the inhibitor of &#x003ba;B kinase (IKK) complex (<xref rid="bib0009" ref-type="bibr">Baker&#x000a0;et&#x000a0;al., 2011</xref>). The IKK complex phosphorylates I&#x003ba;B&#x003b1; and induces its degradation, leading to the release and nuclear translocation of NF-&#x003ba;B to promote transcription of target genes such as TNF-&#x003b1;, interleukin-1beta (IL-1&#x003b2;), IL-6, IL-8, cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) (<xref rid="bib0071" ref-type="bibr">Knab&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0105" ref-type="bibr">Ruan&#x000a0;et&#x000a0;al., 2011</xref>).</p><p id="para0010">On the other hand, JNK are members of the mitogen-activated protein kinases (MAPK) that mediate cellular responses to a variety of intra- and extracellular stresses (<xref rid="bib0137" ref-type="bibr">Zeke&#x000a0;et&#x000a0;al., 2016</xref>). In the context of obesity, JNK pathways can be activated by proinflammatory cytokines, FFA and reactive oxygen species (ROS), and regulate several nuclear and extra-nuclear substrates, specially the transcription factor activator protein 1 (AP1) which controls the expression of proinflammatory genes and protein synthesis (<italic>e.g.</italic> TNF-&#x003b1;, IL-1&#x003b2;, IL-6 and IL-8) (<xref rid="bib0097" ref-type="bibr">Pal&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0043" ref-type="bibr">Feng&#x000a0;et&#x000a0;al., 2020</xref>). Deregulated activation of NF-&#x003ba;B and JNK pathways results in increased transcription of IL-6 and TNF-&#x003b1;, which reduce the sensitivity of insulin target cells towards insulin. Thus, chronically activated NF-&#x003ba;B and JNK pathways leads to the promotion of insulin resistance (<xref rid="bib0135" ref-type="bibr">Yung&#x000a0;and Giacca,&#x000a0;2020</xref>).</p><p id="para0011">Additionally, increased flux of FFA to the liver in the insulin resistant state stimulates production TG and secretion in the form of very-low-density lipoprotein (VLDL). The resulting hypertriglyceridemia leads to lower HDL&#x02010;C levels and normal or slightly elevated low-density lipoprotein-cholesterol (LDL-C) levels (<xref rid="bib0059" ref-type="bibr">Iqbal&#x000a0;et&#x000a0;al., 2018</xref>). This is related to the typical dyslipidemic profile in MetS.</p><p id="para0012">Consistent with a potential role in the pathogenesis of MetS, SLns interfering with these processes described above could be useful to prevent the onset of insulin resistance and the risk of T2DM and CVD in obese individuals.</p></sec><sec id="sec0005"><label>5</label><title>Sesquiterpene lactones</title><p id="para0013">SLns represent a diverse group of terpenoids with more than 5000 different elucidated structures. They are particularly diversified in the Compositae (Asteraceae) family, but also occurring in Apiaceae, Illiciaceae, Magnoliaceae, Solanaceae, and Euphorbiaceae families (<xref rid="bib0096" ref-type="bibr">Padilla-Gonzalez&#x000a0;et&#x000a0;al., 2016</xref>). Numerous species of these families are used in traditional medicine and SLns have been described as their primary active constituents. These compounds possess several biological activities such as anti-inflammatory, antidiabetic, antimalarial, anti-proliferative, anti- parasitic and antimicrobial (<xref rid="bib0085" ref-type="bibr">Merfort,&#x000a0;2011</xref>; <xref rid="bib0021" ref-type="bibr">Chadwick&#x000a0;et&#x000a0;al., 2013</xref>; <xref rid="bib0023" ref-type="bibr">Chaturvedi&#x000a0;et&#x000a0;al., 2011</xref>).</p><p id="para0014">SLns are characterized by the presence of a &#x003b3;-lactone ring. The lactone ring can be fused to the remaining skeleton in either a <italic>cis</italic> or <italic>trans</italic> configuration, being most common the <italic>trans</italic> configuration (<xref rid="bib0045" ref-type="bibr">Fischer&#x000a0;et&#x000a0;al., 1979</xref>; <xref rid="bib0044" ref-type="bibr">Fischer,&#x000a0;1990</xref>; <xref rid="bib0121" ref-type="bibr">S&#x000fc;lsen&#x000a0;and Martino,&#x000a0;2018</xref>). Based on their carbocyclic skeleton, SLns are mainly classified in four major groups: germacranolides (10-membered ring), eudesmanolides (6&#x02013;6 bicyclic compounds), guaianolides and pseudoguaianolides (5&#x02013;7 bicyclic compounds) and many subtypes of SLns according to their skeletal arrangement (<xref rid="bib0001" ref-type="bibr">Adekenov,&#x000a0;2017</xref>; <xref rid="bib0096" ref-type="bibr">Padilla-Gonzalez&#x000a0;et&#x000a0;al., 2016</xref>). In many cases, the &#x003b3;-lactone ring contains an exocyclic double bond conjugated to the carbonyl group (&#x003b1;-methylene-&#x003b3;-lactone) but in some cases the exocyclic methylene is reduced or the double bond can be endocyclic (<xref rid="bib0084" ref-type="bibr">Mart&#x000ed;nez&#x000a0;et&#x000a0;al., 2012</xref>; <xref rid="bib0096" ref-type="bibr">Padilla-Gonzalez&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0120" ref-type="bibr">S&#x000fc;lsen&#x000a0;et&#x000a0;al., 2018</xref>). It has been well documented that biological activity of the most common types of SLns is mainly attributed to formation of covalent union between the &#x003b1;,&#x003b2;-unsaturated group in the <italic>exo</italic>-methylene-&#x003b3;-lactone and nucleophilic biological targets (<italic>e.g.</italic> free cysteine sulfhydryl) resulting in alkylation through Michael-type addition (<xref rid="bib0107" ref-type="bibr">Schmidt,&#x000a0;2006</xref>). This chemical reaction induces steric and chemical changes in enzymes, receptors or transcriptional factors leading to a series of cellular events that culminate in diverse biologic responses. The number of alkylating structural elements present on the molecule define differences between the activity of each SLn. Another structural influences on the biological effects are the molecular size, hydrophobicity, chemical environment and the presence of other functional groups (<italic>e.g.</italic>, epoxy groups, hydroxyls or hydroxyls esterified with acetate, propionate, isobutyrate, angelate, epoxyangelate, and benzoate) (<xref rid="bib0023" ref-type="bibr">Chaturvedi,&#x000a0;2011</xref>; <xref rid="bib0060" ref-type="bibr">Ivanescu&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0096" ref-type="bibr">Padilla-Gonzalez&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0120" ref-type="bibr">S&#x000fc;lsen&#x000a0;et&#x000a0;al., 2018</xref>).</p><p id="para0015">The structural diversity and the broad spectrum of biological activities drew significant interests in the pharmacological applications of SLns (<xref rid="bib0089" ref-type="bibr">Moujir&#x000a0;et&#x000a0;al., 2020</xref>). Many SLns have proved to have a significant anti-inflammatory, hypoglycemic and hypolipidemic activity therefore making them attractive for MetS therapy (<xref rid="bib0023" ref-type="bibr">Chaturvedi,&#x000a0;2011</xref>; <xref rid="bib0024" ref-type="bibr">Chaturvedi&#x000a0;et&#x000a0;al., 2016</xref>).</p></sec><sec id="sec0006"><label>6</label><title>SLns isolated from medicinal plants and their potential role for MetS treatment</title><sec id="sec0007"><label>6.1</label><title>Enhydrin from <italic>Smallanthus sonchifolius</italic> (Poepp.) H.Rob</title><p id="para0016">
<italic>Smallanthus sonchifolius</italic> (Poepp.) H.Rob., commonly known as yacon, is a perennial herbaceous plant native to the Andean regions of South America (<xref rid="bib0016" ref-type="bibr">Caetano&#x000a0;et&#x000a0;al., 2016</xref>). Yacon is consumed as a safety dietary supplement and because of its low glucose content and high fructooligosaccharide levels putative antidiabetic effects were suggested (<xref rid="bib0032" ref-type="bibr">Delgado&#x000a0;et&#x000a0;al., 2013</xref>). Indeed, this suggestion is supported by the hypoglycemic (<xref rid="bib0008" ref-type="bibr">Aybar&#x000a0;et&#x000a0;al., 2001</xref>; <xref rid="bib0011" ref-type="bibr">Baroni&#x000a0;et&#x000a0;al., 2008</xref>) and hypolipidemic (<xref rid="bib0087" ref-type="bibr">Miura&#x000a0;et&#x000a0;al., 2004</xref>; <xref rid="bib0052" ref-type="bibr">Habib&#x000a0;et&#x000a0;al., 2011</xref>) reported activities. Also, a potential use in metabolic disorders could be proposed based on the anti-inflammatory and antioxidant properties (<xref rid="bib0042" ref-type="bibr">Feltenstein&#x000a0;et&#x000a0;al., 2004</xref>; <xref rid="bib0118" ref-type="bibr">Sousa&#x000a0;et&#x000a0;al., 2015</xref>). Besides the above mentioned evidences, enhydrin (<bold>1</bold>), a melampolide (<italic>cis,trans</italic>-germacranolide) and the major sesquiterpene lactone component in leaves of <italic>S. sonchifolius</italic>, has proven to be effective reducing post-prandial glucose levels and a useful compound for blood glucose control by the induction of a late increase in plasma insulin in streptozotocin (STZ)-induced diabetic rats (<xref rid="bib0047" ref-type="bibr">Genta&#x000a0;et&#x000a0;al., 2010</xref>). More recently, <italic>in vivo</italic> and <italic>in vitro</italic> experiments showed that enhydrin (<bold>1</bold>) is effective in the management of post-prandial hyperglycemia through inhibition of &#x003b1;-glucosidase in the small intestine (<xref rid="bib0112" ref-type="bibr">Serra-Barcellona&#x000a0;et&#x000a0;al., 2017</xref>). The inhibition of this enzyme has been linked to the presence of the &#x003b1;,&#x003b2;-unsaturated&#x003b3;-lactone ring system (<xref rid="bib0134" ref-type="bibr">Yin&#x000a0;et&#x000a0;al., 2014</xref>), similar to the intact <italic>exo</italic>-methylene-&#x003b3;-lactone group in <bold>1</bold> (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>
). Thus, the anti- &#x003b1;-glucosidase activity of enhydrin could be derived from this interaction. In addition, the alkylation of nucleophilic sites of factors involved in early stages of the inflammatory cascade described above allows to relate the anti-inflammatory properties reported for <bold>1</bold> with the presence of the <italic>exo</italic>-methylene-&#x003b3;-lactone ring system (<xref rid="bib0042" ref-type="bibr">Feltenstein&#x000a0;et&#x000a0;al., 2004</xref>; <xref rid="bib0083" ref-type="bibr">Ma&#x000a0;et&#x000a0;al., 2007</xref>).<fig id="fig0001"><label>Fig. 1</label><caption><p>Chemical structures of compounds <bold>1</bold>-<bold>13</bold>.</p></caption><alt-text id="alt0001">Fig 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p><p id="para0017">Regarding toxicological studies, it has been reported that a single oral administration of enhydrin (<bold>1</bold>) at doses of 1.6, 4 and 8&#x000a0;mg/kg body weight (b.w.) did not caused deaths or acute toxic effects within 7 days in male and female rats (<xref rid="bib0047" ref-type="bibr">Genta&#x000a0;et&#x000a0;al., 2010</xref>). In acute study in rats, there were no deaths or signs of toxicity observed after single oral administration of <bold>1</bold> at any dose level up to the highest dose tested (0.32&#x000a0;g/kg b.w.) within 14 days. In subchronic studies, after oral administration for 90 days at daily doses of 0.4, 0.8 and 8.0&#x000a0;mg/kg b.w., did not caused hematological, biochemical and histological alterations in rats (<xref rid="bib0110" ref-type="bibr">Serra&#x000a0;et&#x000a0;al., 2012</xref>).</p></sec><sec id="sec0008"><label>6.2</label><title>Polymatin A from <italic>Smallanthus macroscyphus</italic> (Baker ex Baker) A. Grau</title><p id="para0018">
<italic>Smallanthus macroscyphus</italic> (Heliantheae, Asteraceae), is a perennial herb commonly known as &#x02018;&#x02018;wild yacon&#x02019;&#x02019; native from the South American region comprising from southern Bolivia to northwestern Argentina. This species is closely related to <italic>S. sonchifolius</italic> and possibly with similar antidiabetic properties. Polymatin A (<bold>2</bold>) is the main sesquiterpene lactone isolated from <italic>S. macroscyphus</italic> (<xref rid="bib0031" ref-type="bibr">De&#x000a0;Pedro et&#x000a0;al., 2003</xref>). This melampolide exerts an effective inhibition of post-prandial blood glucose peak and hypoglycemic activity in STZ-diabetic rats probably by the stimulation of insulin release or due to an insulin-like effect (<xref rid="bib0111" ref-type="bibr">Serra-Barcellona&#x000a0;et&#x000a0;al., 2014</xref>). Due to the close relationship in the polymatin A (<bold>2</bold>) and enhydrin (<bold>1</bold>) structures, the melampolide <bold>2</bold> could be effective in the management of postprandial hyperglycemia through inhibition of &#x003b1;-glucosidase. However, no studies of these effects were found.</p><p id="para0019">In contrast to the C4&#x02013;C5 epoxy group in enhydrin (<bold>1</bold>), polymatin A (<bold>2</bold>) presents a double bond (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>). C4&#x02013;C5 epoxy groups in melampolides such as enhydrin have been reported to hinder the ability of these compounds to inhibit NF-&#x003ba;B DNA binding responsible to cytokines expression (<xref rid="bib0108" ref-type="bibr">Schorr&#x000a0;et&#x000a0;al., 2007</xref>) commonly observed in inflammatory response. Conversely, the effect is favored by the presence of a double bond between C-4&#x02013;C-5 in other melampolides (<xref rid="bib0108" ref-type="bibr">Schorr&#x000a0;et&#x000a0;al., 2007</xref>). Hence, hopeful results could be expected in future studies to explore anti-inflammatory activity in polymatin A.</p><p id="para0020">Acute oral toxicity of polymatin A (<bold>2</bold>) in normal healthy rats at doses assayed (0.7, 1.4 and 2.8&#x000a0;g dried powder/kg b.w.) do not produced deaths or acute toxic effect (changes in behavior or posture, presence of convulsions or occurrence of secretions) within 14 days. The doses were well tolerated and did not produce adverse nutritional effect. No gastrointestinal symptom such as diarrhea or constipation were observed at the doses assayed. Volume, pH and urine specific gravity were within normal ranges. No nitrites, protein or blood were detected in the urine samples of the animal groups treated (<xref rid="bib0111" ref-type="bibr">Serra-Barcellona&#x000a0;et&#x000a0;al., 2014</xref>).</p><p id="para0021">In subchronic studies, polymatin A (<bold>2</bold>) was orally administered to Wistar rats for 90 days at daily doses of 7, 14 and 28&#x000a0;mg/kg b.w. No toxicity signs or deaths were observed. There were no changes in the behavior, body or organ weights, hematological, biochemical or urine parameters of the rats. No histopathological lesions were observed in the examined organs. The results indicate that polymatin A (<bold>2</bold>) from <italic>S. macroscyphus</italic> leaves may be considered as nontoxic substance at a wide range of doses (<xref rid="bib0113" ref-type="bibr">Serra-Barcellona., 2016</xref>).</p></sec><sec id="sec0009"><label>6.3</label><title>20-dehydroeucannabinolide from <italic>Helianthus annuus</italic> Linn</title><p id="para0022">The common sunflower, <italic>Helianthus annuus</italic> Linn (Asteraceae), is a well-known plant with edible seeds, flower petals and tender leaf petioles. This plant was proposed to offer a variety of medical benefits (<xref rid="bib0078" ref-type="bibr">Lim,&#x000a0;2014</xref>; <xref rid="bib0050" ref-type="bibr">Guo&#x000a0;et&#x000a0;al., 2017</xref>). To provide a scientific explanation for its use in Nigerian traditional medicine, <xref rid="bib0092" ref-type="bibr">Onoja&#x000a0;and Anaga&#x000a0;(2014)</xref> reported a hypoglycemic effect on the fasting blood glucose level in alloxan-induced diabetic rats after a single dose of the methanolic extract of <italic>H. annuus</italic> leaves. This study led to the recent isolation of the heliangolide 20-dehydroeucannabinolide (<bold>3</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>). (<xref rid="bib0093" ref-type="bibr">Onoja&#x000a0;et&#x000a0;al., 2020</xref>). Heliangolide SLns represent an isomeric form of germacranolides with a cyclodecadiene skeleton and double bonds at C1=C10 and C4=C5, which stereochemical configurations are <italic>trans, cis</italic> respectively (<xref rid="bib0121" ref-type="bibr">S&#x000fc;lsen&#x000a0;and Martino,&#x000a0;2018</xref>). The heliangolide <bold>3</bold> reduced the fasting blood glucose level at dose of 0.2&#x000a0;mmol/kg in alloxan-induced diabetic rats (<xref rid="bib0093" ref-type="bibr">Onoja&#x000a0;et&#x000a0;al., 2020</xref>). The authors suggested that this sesquiterpene lactone might have reducing effects in glucose absorption based on the heliangolide derivative structure, which presents an intact <italic>exo</italic>-methylene-&#x003b3;-lactone group. As mentioned above, &#x003b1;,&#x003b2;-unsaturated &#x003b3;-lactone ring system has an important relation in the inhibition of <italic>&#x003b1;</italic>-glucosidase activity, thus the heliangolide <bold>3</bold> may be inhibiting this enzyme similar to enhydrin <bold>(1</bold>).</p><p id="para0023">In addition to blood glucose regulation, it has also been demonstrated the positive effects of hydromethanolic leaf extract of <italic>H. annuus</italic> L. on other components of MetS, including reduced LDL-C and TG levels as well as hepatoprotective and antilipid peroxidation activities of alloxan-induced diabetic rats (<xref rid="bib0094" ref-type="bibr">Onoja&#x000a0;et&#x000a0;al., 2018</xref>). Since 20-dehydroeucannabinolide (<bold>3</bold>) is one of the major components of the extract, potential activity of this molecule in managing dyslipidemia may be proposed. However, additional studies are needed to ascertain the hypolipidemic property of this compound.</p><p id="para0024">No <italic>in vivo</italic> toxicity studies on 20-dehydroeucannabinolide (<bold>3</bold>) have been reported to date.</p></sec><sec id="sec0010"><label>6.4</label><title>Costunolide and eremanthin from <italic>Costus speciosus</italic> (J. Koenig) Sm</title><p id="para0025">
<italic>Costus speciosus</italic> (J. Koenig) Sm is a plant used in traditional medicine in South Asia to treat diabetic patients by eating one leaf of this species per day to regulate blood glucose levels (<xref rid="bib0128" ref-type="bibr">Waisundara&#x000a0;et&#x000a0;al., 2015</xref>). Also, the hypoglycemic effect of <italic>C. speciosus</italic> root crude extracts have been reported (<xref rid="bib0030" ref-type="bibr">Daisy&#x000a0;et&#x000a0;al., 2008</xref>). Eremanthin (<bold>4</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>) is a guaianolide sesquiterpene lactone present in <italic>C. speciosus</italic> and other plants such as <italic>Pterodon pubescens</italic> (Benth.) Benth., <italic>Eremanthus elaeagnus</italic> (Mart. ex DC.) Sch.Bip. and <italic>Laurus nobilis</italic> L. (<xref rid="bib0039" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2009a</xref>; <xref rid="bib0128" ref-type="bibr">Waisundara&#x000a0;et&#x000a0;al., 2015</xref>). Another sesquiterpene lactone reported to be present in <italic>C. speciosus</italic> is the germacrolide (a <italic>trans,trans</italic>-germacranolide) costunolide (<bold>5</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>) (<xref rid="bib0040" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2009b</xref>), which has been also isolated from <italic>Magnolia</italic> spp, <italic>Laurus nobilis</italic> and <italic>Saussurea costus</italic> (Falc.) Lipsch (<xref rid="bib0073" ref-type="bibr">Koo&#x000a0;et&#x000a0;al., 2001</xref>).</p><p id="para0026">Studies in STZ-induced diabetic rats showed that oral administration of <bold>4</bold> and <bold>5</bold> decreased plasma glucose level, glycosylated hemoglobin (HbA1c), total cholesterol (TC), TG, LDL-C and at the same time markedly increased plasma insulin, tissue glycogen and HDL-C (<xref rid="bib0039" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2009a</xref>, <xref rid="bib0040" ref-type="bibr">2009b</xref>). The specific mechanism of eremanthin (<bold>4</bold>) bioactivity is not completely characterized, but the experimental model used in both works allowed the authors to suggest that this molecule might exert an insulin-like effect on peripheral tissues by either promoting glucose uptake metabolism, by inhibiting hepatic gluconeogenesis or by absorption of glucose into the muscle and adipose tissues through the stimulation of a regeneration process and revitalization of the remaining &#x003b2; cells (<xref rid="bib0039" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2009a</xref>, <xref rid="bib0040" ref-type="bibr">2009b</xref>).</p><p id="para0027">In addition, costunolide (<bold>5</bold>) has shown to suppress LPS-induced NF-&#x003ba;B activation that leads to the suppression of iNOS and a consequent nonproduction of NO. This activity was stronger than the observed for parthenolide, a germacranolide sesquiterpene lactone (<xref rid="bib0073" ref-type="bibr">Koo&#x000a0;et&#x000a0;al., 2001</xref>). Thus, the anti-inflammatory activity exhibited by <bold>5</bold> serve as a promising and expanding strategy for treatment of metabolic disease-associated inflammation.</p><p id="para0028">On the other hand, the possible inhibition of inflammatory processes has not been studied in eremanthin (<bold>4</bold>). However, this compound has a rigid skeleton and an intact <italic>exo</italic>-methylene-&#x003b3;-lactone group, previously related to anti-inflammatory properties (<xref rid="bib0116" ref-type="bibr">Simonsen&#x000a0;et&#x000a0;al., 2013</xref>). Additionally, the absence of free hydroxyl groups in <bold>4</bold> could help to improve anti-inflammatory properties since an increasing number of free hydroxyl groups are reported to diminish NF-&#x003ba;B inhibition activity (<xref rid="bib0116" ref-type="bibr">Simonsen&#x000a0;et&#x000a0;al., 2013</xref>). Taking together these structural characteristics, we suggest that eremathin (<bold>4</bold>) is a candidate to be tested for inhibition of inflammatory processes related to metabolic diseases.</p><p id="para0029">Acute oral toxicity of eremanthin (<bold>4</bold>) and costunolide (<bold>5</bold>) in normal healthy male Wistar rats at doses assayed (10, 20, 40, 80 and 160&#x000a0;mg/kg b.w.) do not produced behavioral changes on the rats and mortality was not observed during acute toxicity test (10 days) (<xref rid="bib0038" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2010</xref>).</p><p id="para0030">Finally, the antioxidant activity of eremanthin (<bold>4</bold>) and costunolide (<bold>5</bold>) has been demonstrated by significantly decreasing of the thiobarbituric acid reactive substances (TBARS) and lipid peroxidation markers levels as well as by increasing reduced glutathione (GSH) levels and enzymatic antioxidants (<xref rid="bib0038" ref-type="bibr">Eliza&#x000a0;et&#x000a0;al., 2010</xref>). This activity could indicate a protective effect of both on oxidative stress in diabetes.</p></sec><sec id="sec0011"><label>6.5</label><title>Alantolactone from <italic>Inula</italic> spp</title><p id="para0031">
<italic>Inula</italic> (Asteraceae) is one of the most popular herbs in Traditional Chinese Medicine. This genus comprises more than one hundred species widely distributed throughout Asia, Africa, and Europe, and many of these have been used to treat a wide range of diseases such as bronchitis, diabetes, obesity, hypertension, and inflammation (<xref rid="bib0109" ref-type="bibr">Seca&#x000a0;et&#x000a0;al., 2014</xref>). Extracts of <italic>Inula</italic> spp. such as <italic>Inula britannica</italic> L., <italic>Inula viscosa</italic> [the accepted name is <italic>Dittrichia viscosa</italic> (L.) Greuter.], <italic>Inula racemosa</italic> Hook.f.<italic>, Inula helenium</italic> L., etc., have been documented for their potential effects on some components of MetS, especially hypoglycemic, hypolipidemic and antioxidant activities (<xref rid="bib0072" ref-type="bibr">Kobayashi&#x000a0;et&#x000a0;al., 2002</xref>; <xref rid="bib0136" ref-type="bibr">Zeggwagh&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0114" ref-type="bibr">Shan&#x000a0;et&#x000a0;al., 2006</xref>; <xref rid="bib0002" ref-type="bibr">Ajani&#x000a0;et&#x000a0;al., 2009</xref>) as well as inhibition of &#x003b1;-glucosidase enzyme (<xref rid="bib0095" ref-type="bibr">Orhan&#x000a0;et&#x000a0;al., 2017</xref>). Regarding bioactive secondary metabolites, SLns represent the largest group of compounds occurring in <italic>Inula</italic> spp. Many of these compounds were isolated from plants mentioned above and demonstrated to exert diverse biological activities (<xref rid="bib0109" ref-type="bibr">Seca&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0129" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>). The anti-inflammatory mechanisms of some SLns have been related to their influence on directly inhibit the MAPK and block the activation of NF-&#x003ba;B, thus achieving the prevention of pro-inflammatory signaling (<xref rid="bib0053" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2001</xref>; <xref rid="bib0098" ref-type="bibr">Park&#x000a0;et&#x000a0;al., 2013</xref>).</p><p id="para0032">Alantolactone (<bold>6</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>) is the most known eudesmanolide present in several <italic>Inula</italic> species, including <italic>Inula helenium</italic> L. used for hypoglycemic and antiobesity purposes (<xref rid="bib0109" ref-type="bibr">Seca&#x000a0;et&#x000a0;al., 2014</xref>; <xref rid="bib0129" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2014</xref>). This compound has been extensively studied for its antitumor, antioxidant and anti-inflammatory effects (<xref rid="bib0089" ref-type="bibr">Moujir&#x000a0;et&#x000a0;al., 2020</xref>). Regarding anti-inflammatory activity, the eudesmanolide <bold>6</bold> suppresses NO, PGE<sub>2</sub> and TNF-&#x003b1; production in LPS-stimulated RAW 264.7 cells by modulating the activity of the NF-&#x003ba;B and MAPK signaling pathways (<xref rid="bib0027" ref-type="bibr">Chun&#x000a0;et&#x000a0;al., 2012</xref>), and it also suppresses TNF-&#x003b1; and interferon gamma (IFN-&#x003b3;)-induced production of chemokines by blocking the Signal Transducer and Activator of Transcription 1 (STAT1) phosphorylation in HaCaT cells (<xref rid="bib0077" ref-type="bibr">Lim&#x000a0;et&#x000a0;al., 2015</xref>).</p><p id="para0033">As previously mentioned, it is recognized the fact that TLRs are responsible for the activation of inflammatory pathways in obesity state. <italic>In vitro</italic> trials confirmed that alantolactone (<bold>6</bold>) prevents the increase of IL-6 levels and regulates macrophage infiltration by reduction of MCP-1 concentrations via inhibition of the TLR4-JNK pathway in both, lean (adipocytes) and obese (adipocyte-macrophage) states (<xref rid="bib0067" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2017</xref>a, <xref rid="bib0068" ref-type="bibr">2017b</xref>).</p><p id="para0034">Besides the effect on adipocytes, alantolactone (<bold>6</bold>) can also act in skeletal muscle and liver cells. In this context, the compound <bold>6</bold> inhibits IL-6-induced insulin-stimulated glucose intolerance and insulin resistance in the skeletal muscle through blockade the activation of STAT3 and the abnormal expression of TLR4 (<xref rid="bib0067" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2017a</xref>, <xref rid="bib0068" ref-type="bibr">2017b</xref>). In L02 cells, alantolactone (<bold>6</bold>) also inhibits oxLDL-induced lipid accumulation trough regulating the apolipoprotein C3 (APOC3) expression partly by decreasing the activation of STAT3 (<xref rid="bib0133" ref-type="bibr">Yang&#x000a0;et&#x000a0;al., 2018</xref>). Thus, may be relevant to explore further its role in managing metabolic complications on <italic>e.g.</italic> modulating hepatic IL-6/STAT3 signaling in high-fat diet-induced metabolic disorder in animal models, since the physiological metabolic response to IL-6 depends on the specific source of IL-6 <italic>in vivo</italic> (<xref rid="bib0054" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2020</xref>)</p><p id="para0035">Concerning to <italic>in vivo</italic> experiments, no hypoglycemic effect was observed on STZ-induced diabetic mice after oral administration of alantolactone. However, inflammation and renal abnormalities were suppressed via inhibition of NF-&#x003ba;B gene expression and the high glucose-induced overexpression of pro-inflammatory cytokines and macrophage adhesion in renal NRK-52E cells were inhibited. (<xref rid="bib0142" ref-type="bibr">Zhu&#x000a0;et&#x000a0;al., 2020</xref>). These results led the authors to propose a beneficial use for the treatment of diabetic neuropathy. Taking together all evidences mentioned for alantolactone (<bold>6</bold>) activity, it is probably that this compound could reduce some components of MetS by the regulation of inflammatory processes.</p><p id="para0036">Alantolactone (<bold>6</bold>) did not induced significant hepatotoxicity and nephrotoxicity after daily administration (100&#x000a0;mg/kg b.w.) for 5 weeks in mice (<xref rid="bib0065" ref-type="bibr">Khan&#x000a0;et&#x000a0;al., 2012</xref>). This compound also is a contact allergen, and <italic>in vitro</italic> is cytotoxic in cancer cells and induces apoptosis (<xref rid="bib0125" ref-type="bibr">Tisserand and Young,&#x000a0;2014</xref>).</p></sec><sec id="sec0012"><label>6.6</label><title>3,10-Epoxygermacranolides from <italic>Tithonia diversifolia</italic> (Hemsl.) A. Gray</title><p id="para0037">
<italic>Tithonia diversifolia</italic> (Hemsl) A. Gray, commonly known as tree marigold or Mexican sunflower (Asteraceae: Heliantheae), is a shrub-like perennial or annual invasive plant, native from North and Central America. Traditionally, its leaves are widely used by indigenous people for treating a wide spectrum of diseases, including diabetes mellitus. Several <italic>in vitro</italic> and <italic>in vivo</italic> studies have stated the antioxidant antidiabetic, hypolipidemic and antiobesity effects of <italic>T. diversifolia</italic> (<xref rid="bib0003" ref-type="bibr">Ajao&#x000a0;and Moteetee,&#x000a0;2017</xref>; <xref rid="bib0124" ref-type="bibr">Tagne&#x000a0;et&#x000a0;al., 2018</xref>). Germacranolides, eudesmanolides and guaianolides are some of the major components occurring in this plant (<xref rid="bib0003" ref-type="bibr">Ajao&#x000a0;and Moteetee,&#x000a0;2017</xref>; <xref rid="bib0124" ref-type="bibr">Tagne&#x000a0;et&#x000a0;al., 2018</xref>) and because of their previously described activity, they apparently are involved in the important spectrum of bioactivity reported for <italic>T. diversifolia</italic>. Tirotundin (<bold>7</bold>) and tagitinin A (<bold>8</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>) isolated from the ethyl acetate soluble fraction of <italic>T. diversifolia</italic> are related to the activation of peroxisome proliferator-activated receptors (PPARs) (<xref rid="bib0079" ref-type="bibr">Lin,&#x000a0;2012</xref>). PPARs are members of nuclear hormone receptors superfamily involved in the metabolic regulation of lipid and lipoprotein levels, blood glucose, and abdominal adiposity. In mammals, three isoforms of PPARs have been recognized namely PPAR-&#x003b1;, PPAR-&#x003b2;/&#x003b4; and PPAR-&#x003b3;. Activation of PPAR-&#x003b1; by hypolipidemic fibrate class of drugs decreases TG levels and raises HDL-C in dyslipidemic individuals, whereas activation of PPAR-&#x003b3; by antidiabetic thiazolidinedione agents causes insulin sensitization to enhance glucose metabolism (<xref rid="bib0013" ref-type="bibr">Botta&#x000a0;et&#x000a0;al., 2018</xref>). Currently, dual PPAR&#x003b1;/&#x003b3; agonists, which stimulate both PPAR&#x003b1; and PPAR-&#x003b3; isoforms to similar extents, are gaining popularity since it is believed that they are able to ameliorate the unwanted side effects of selective PPAR-&#x003b1; and PPAR-&#x003b3; agonists; and may also be used to treat dyslipidemia and T2DM simultaneously (<xref rid="bib0010" ref-type="bibr">Balakumar&#x000a0;et&#x000a0;al., 2019</xref>). Tirotundin (<bold>7</bold>) and tagitinin A (<bold>8</bold>) have been suggested being dual PPAR&#x003b1;/&#x003b3; agonists after the evaluation of their agonistic activity against PPARs employing a transient transfection reporter assay in HepG2 cells (<xref rid="bib0079" ref-type="bibr">Lin&#x000a0;et&#x000a0;al., 2012</xref>).</p><p id="para0038">On the other hand, the germacranolides tagitinin G (<bold>9</bold>), tagitinin I (<bold>10</bold>), 1&#x003b2;-hydroxydiversifolin-3-<italic>O</italic>-methyl ether (<bold>11</bold>) and 1&#x003b2;-hydroxytirotundin-3-<italic>O</italic>-methyl ether (<bold>12</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>) isolated from the aerial parts of <italic>T. diversifolia</italic> were found to significantly elevate glucose uptake in 3T3-L1 adipocytes without any toxicity (<xref rid="bib0139" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2012</xref>). The authors suggested that these compounds had PPAR&#x003b3; agonist activity on glucose uptake, similar to pioglitazone, a PPAR-&#x003b3; agonist used as a control compound in the study. No <italic>in vivo</italic> acute, subchronic or chronic toxicity studies on 3,10-epoxygermacranolides described above have been reported to date.</p><p id="para0039">The increasing abundance of <italic>Tithonia diversifolia</italic> in conservation and agricultural areas over the past ten years in South Africa has been of concern. This plant is considered as a scrub resulting in the initiation of a biological control program against its propagation (<xref rid="bib0115" ref-type="bibr">Simelane&#x000a0;et&#x000a0;al., 2011</xref>). Therefore, utilization for medicinal purposes of this invasive plant could be important before major eradication takes place.</p></sec><sec id="sec0013"><label>6.7</label><title>Micheliolide from <italic>Magnolia compressa</italic> (Maxim.) Sarg</title><p id="para0040">The genus <italic>Magnolia</italic>, previously known as <italic>Michellia</italic>, reported to exert various biological effects, including anti-cancer, anti-anxiety, antidepressant, antioxidant and anti-inflammatory (<xref rid="bib0075" ref-type="bibr">Lee&#x000a0;et&#x000a0;al., 2011</xref>). In later years, <italic>Magnolia</italic> species and their components have been related to ameliorate characters of obesity and diabetes, such as hyperglycemia, hyperlipidemia, and other complications (<xref rid="bib0140" ref-type="bibr">Zhao&#x000a0;et&#x000a0;al., 2016</xref>). Since terpenoids are one of the principal substantial compounds in <italic>Magnolia</italic> species, SLns may be related with its medicinal properties (<xref rid="bib0122" ref-type="bibr">Sun&#x000a0;et&#x000a0;al., 2015</xref>). Anticancer activity investigation lead to the isolation of the guaianolide micheliolide (<bold>13</bold>) (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>) from <italic>M. compressa</italic> (Maxim.) Sarg. (<xref rid="bib0091" ref-type="bibr">Ogura&#x000a0;et&#x000a0;al., 1978</xref>). This compound has also been obtained in a semi-synthetic way from a BF<sub>3</sub>-mediated rearrangement of parthenolide (<xref rid="bib0018" ref-type="bibr">Casta&#x000f1;eda-Acosta&#x000a0;et&#x000a0;al., 1993</xref>; <xref rid="bib0138" ref-type="bibr">Zhai&#x000a0;et&#x000a0;al., 2012</xref>), presenting enhanced stability and remarkable anti-inflammatory effect by suppressing activation of the NF-&#x003ba;B through inhibition of I&#x003ba;B&#x003b1; degradation as well as for the inhibition of p65 translocation to the nucleus (<xref rid="bib0127" ref-type="bibr">Viennois&#x000a0;et&#x000a0;al., 2014</xref>). The compound also influenced the MAPK and PI3K/Akt signaling pathways in LPS-stimulated BV-2 cells (<xref rid="bib0123" ref-type="bibr">Sun&#x000a0;et&#x000a0;al., 2017</xref>). Further, an <italic>in vitro</italic> assay has revealed that <bold>13</bold> attenuate the high glucose-stimulated activation of NF-&#x003ba;B, the degradation of I&#x003ba;B&#x003b1;, and the expression of MCP-1 in rat mesangial cells (<xref rid="bib0061" ref-type="bibr">Jia&#x000a0;et&#x000a0;al., 2013</xref>).</p><p id="para0041">In addition, the dimethylamino Michael adduct of <bold>13</bold> known as dimethylaminomicheliolide is a pro-drug of this sesquiterpene lactone approved for clinical trials for glioblastoma treatment (<xref rid="bib0049" ref-type="bibr">Guo&#x000a0;et&#x000a0;al., 2019</xref>). This compound protects the kidneys against proteinuria, renal failure, histopathological injury, and inflammation by suppressing activation of the NF-&#x003ba;B signaling pathway in db/db mice (<xref rid="bib0080" ref-type="bibr">Liu&#x000a0;et&#x000a0;al., 2019</xref>). These results showed that dimethylaminomicheliolide intervention mitigated diabetic kidney disease in db/db mice without directly affecting hyperglycemia.</p><p id="para0042">Furthermore, it has been demonstrated that micheliolide (<bold>13</bold>) alleviates hepatic steatosis in obese db/db mice, and the molecular mechanisms driving the therapeutic effects of this compound might involve PPAR-&#x003b3; upregulation to consequently inhibit NF-&#x003ba;B mediated inflammation and activate AMPK/mTOR-dependent autophagy (<xref rid="bib0141" ref-type="bibr">Zhong&#x000a0;et&#x000a0;al., 2018</xref>). Thus, it will be interesting to future work evaluate if this effect in hepatic steatosis impacts glucose metabolism. No <italic>in vivo</italic> toxicity studies on micheliolide (<bold>13</bold>) have been reported to date.</p></sec><sec id="sec0014"><label>6.8</label><title>Byrsonines A and B from <italic>Byrsonima crassifolia</italic> (L.) Kunth</title><p id="para0043">
<italic>Byrsonima crassifolia</italic> (Malpighiaceae), commonly known as &#x0201c;nanche&#x0201d;, is a tropical tree widely distributed in Mexico, Central and South America. This tree is commonly harvested, both for its edible fruit and for its health benefits (<xref rid="bib0012" ref-type="bibr">B&#x000e9;jar&#x000a0;and Malone,&#x000a0;1993</xref>; <xref rid="bib0034" ref-type="bibr">Duarte,&#x000a0;2011</xref>). In folk medicine, the fruit or bark infusion have been used as hypoglycemic remedy (<xref rid="bib0007" ref-type="bibr">Andrade-Cetto and Heinrich,&#x000a0;2005</xref>) and according to ethnomedicinal reports, the antihyperglycemic activity of hexane and chloroform extracts from fruits and seeds of <italic>B. crassifolia</italic> in STZ-induced diabetic rats was reported (<xref rid="bib0099" ref-type="bibr">Perez-Gutierrez&#x000a0;et&#x000a0;al., 2010</xref>). The phytochemical analysis of antihyperglycemic extract from the seed of <italic>B. crassifolia</italic> revealed that byrsonines A (<bold>14</bold>) and B (<bold>15</bold>) (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>
), two dimeric guaianolides, are responsible for the antioxidant, hypoglycemic and hypolipidemic activities (<xref rid="bib0051" ref-type="bibr">Guti&#x000e9;rrez&#x000a0;and Ramirez,&#x000a0;2016</xref>). In particular, it has been proposed that the antihyperglycemic activity of these compounds may involve both pancreatic and extra pancreatic mechanisms, based on the observed increase in serum insulin level and the reduction of hepatic glucose output via decreasing glucose-6-phosphatase (G6Pase) activity and increasing glucokinase activity (<xref rid="bib0051" ref-type="bibr">Guti&#x000e9;rrez&#x000a0;and Ramirez,&#x000a0;2016</xref>). Although the mechanisms underlying the antihyperglycemic activity of <bold>14</bold> and <bold>15</bold> have not been completely explored, this effect could likely be ascribed to the activation AMP-activated protein kinase (AMPK). Activation of the AMPK pathway in the liver regulates glucose homeostasis by inhibiting hepatic glucose production and downregulating the expression of gluconeogenic genes, including G6Pase gene expression. Targeting AMPK by natural products demonstrated considerable success in lowering blood glucose levels (<xref rid="bib0063" ref-type="bibr">Joshi&#x000a0;et&#x000a0;al., 2019</xref>). Nevertheless, more experimental research is needed to substantiate this claim.<fig id="fig0002"><label>Fig. 2</label><caption><p>Chemical structures of compounds <bold>14</bold>-<bold>21</bold></p></caption><alt-text id="alt0002">Fig 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p><p id="para0044">On the other hand, the induction of antioxidant enzymes in hepatic, renal, and pancreas tissues after the administration of <bold>14</bold> and <bold>15</bold>, indicates a positive effect of these molecules in improving glycemic control in STZ-induced diabetic rats (<xref rid="bib0051" ref-type="bibr">Guti&#x000e9;rrez&#x000a0;and Ramirez,&#x000a0;2016</xref>), since oxidative stress takes an important role in the pathogenesis and progression of diabetic tissue injury. In this sense, the reported improvement in insulin resistance by byrsonines A and B can be related to the observed increase in the HDL-C levels and the decrease in TC, TG, LDL-C, and VLDL (<xref rid="bib0051" ref-type="bibr">Guti&#x000e9;rrez&#x000a0;and Ramirez,&#x000a0;2016</xref>). Additionally, TNF-&#x003b1; levels were also decreased after treatment of byrsonines A and B in STZ-induced diabetic rats.</p><p id="para0045">The bioactivity described for <bold>14</bold> and <bold>15</bold> makes them one of the most active guaianolides on different components of MetS reported at this time. As described above, another molecule of this family with activity on different components of MetS is eremathin. However, byrsonines A and B (<bold>14, 15</bold>) seems to be more effective, which could be due to their dimeric structure that provides two possible Michaels acceptors. Dimeric SLns have been found to be more potently cytotoxic than their monomers toward human cancer cells, indicating that the antitumor potential of SLns are improved by the presence of additional &#x003b1;-methylene-&#x003b3;-lactone ring (<xref rid="bib0117" ref-type="bibr">Singh&#x000a0;et&#x000a0;al., 2011</xref>;<xref rid="bib0102" ref-type="bibr">Ren&#x000a0;et&#x000a0;al., 2016</xref>). This phenomenon could be studied in <bold>14</bold> and <bold>15</bold> for MetS treatment due to their extended activity reviewed here. Moreover, pharmacokinetics studies are needed to understand either byrsonines suffer biotransformation reactions and act as monomeric molecules or if they can show biological activity in their original dimeric forms. No <italic>in vivo</italic> toxicity studies on byrsonines A (<bold>14</bold>) and B (<bold>15</bold>) have been reported to date.</p></sec><sec id="sec0015"><label>6.9</label><title>Lactucain from <italic>Lactuca indica</italic> Linn</title><p id="para0046">Various species of the genus <italic>Lactuca</italic> are globally important edible plants containing valuable nutrients such as polyphenols, sterols, vitamins, minerals, and dietary fiber. L. <italic>sativa</italic> L., <italic>Lactuca indica</italic> L. and L. <italic>serriola</italic> L. (syn. L. <italic>scariola</italic> L.) have been used in the treatment of diabetes mellitus, hypertension, and cardiac diseases (<xref rid="bib0035" ref-type="bibr">Eddouks&#x000a0;et&#x000a0;al., 2002</xref>; <xref rid="bib0119" ref-type="bibr">Subramoniam,&#x000a0;2016</xref>). <italic>In vivo</italic> experiments of some <italic>Lactuca</italic> species shown the ability to reduce several metabolic risk factors, especially hyperglycemia, TG and TC (<xref rid="bib0090" ref-type="bibr">Nicolle&#x000a0;et&#x000a0;al., 2004</xref>; <xref rid="bib0106" ref-type="bibr">Salih,&#x000a0;2019</xref>). SLns are commonly found in <italic>Lactuca</italic> species and are represented as subgroups such as lactucin-type guaianolides and the eudesmanolide-type. The latter is commonly found in some species of <italic>Lactuca</italic> such as L. <italic>sativa</italic> L. var. <italic>anagustata</italic>, L. <italic>saligna</italic> L. and L. <italic>canadensis</italic> L. (<xref rid="bib0055" ref-type="bibr">Han&#x000a0;et&#x000a0;al., 2010</xref>; <xref rid="bib0069" ref-type="bibr">Kisiel&#x000a0;and Gromek,&#x000a0;1993</xref>; <xref rid="bib0086" ref-type="bibr">Michalska&#x000a0;et&#x000a0;al., 2013</xref>).</p><p id="para0047">The dimeric guaianolide lactucain C (<bold>16</bold>) (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>), isolated from L. <italic>indica</italic> Linn. showed moderate lowering of plasma glucose in STZ-diabetic rats (<xref rid="bib0058" ref-type="bibr">Hou&#x000a0;et&#x000a0;al., 2003</xref>). Nevertheless, there are no evidences about the possible mechanism of action and no further research has been made about this compound. As mentioned before, dimeric SLns could show an important activity in components of MetS derived from their double &#x003b1;,&#x003b2;-unsaturated &#x003b3;-lactone ring. Because of its hypoglycemic properties and chemical structure, <bold>16</bold> is also a candidate to further studies that analyze deeply its effect in blood glucose levels and some other MetS&#x000b4;s components. No <italic>in vivo</italic> toxicity studies on luctucain C (<bold>16</bold>) have been reported to date.</p></sec><sec id="sec0016"><label>6.10</label><title>8-Deoxylactucin from <italic>Cichorium intybus</italic> L</title><p id="para0048">
<italic>Cichorium intybus</italic>, commonly known as chicory, was historically cultivated by the ancient Egyptians as a vegetable crop, a coffee substitute, and a medicinal plant. Nowadays, it is appreciated for its bitter taste and widely used in India as a traditional treatment for diabetes mellitus (<xref rid="bib0006" ref-type="bibr">Al-Snafi,&#x000a0;2016</xref>; <xref rid="bib0100" ref-type="bibr">Pushparaj&#x000a0;et&#x000a0;al., 2007</xref>). The antidiabetic, hypolipidemic, hepatoprotective, antioxidant and anti-inflammatory effects of <italic>C. intybus</italic> have been widely studied (<xref rid="bib0022" ref-type="bibr">Chandra&#x000a0;and Sk,&#x000a0;2016</xref>). This broad spectrum of biological activities has been attributed to its high content of phytochemical constituents, being SLns the most abundant in roots and the responsible of the bitterness of leaves (<xref rid="bib0006" ref-type="bibr">Al-Snafi,&#x000a0;2016</xref>).</p><p id="para0049">8-deoxylactucin (<bold>17</bold>) (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>) is a guaianolide found as a major component of chicory root and it is also common in species of <italic>Lactuca</italic>. It has been demonstrated that <bold>17</bold> possess anti-inflammatory activity by inhibiting the nuclear transcription factor NF-&#x003ba;B and as a selective inhibitor of COX-2 (<xref rid="bib0020" ref-type="bibr">Cavin&#x000a0;et&#x000a0;al., 2005</xref>). An important structural characteristic of <bold>17</bold> is the presence of &#x003b1;-methylene-&#x003b3;-lactone group and &#x003b1;,&#x003b2;-unsaturated cyclopentenone. Compounds that possess these structures, such as Helenalin, can react with sulfhydryl group of Cys38 in NF-kB and prevent DNA binding (<xref rid="bib0082" ref-type="bibr">Ly&#x000df; et&#x000a0;al., 1998</xref>; <xref rid="bib0131" ref-type="bibr">Widen&#x000a0;et&#x000a0;al., 2017</xref>). Thus, 8-deoxylactucin (<bold>17</bold>) could interact with NF-&#x003ba;B by a similar mechanism. No <italic>in vivo</italic> toxicity studies on 8-deoxylactucin (<bold>17</bold>) have been reported to date.</p></sec><sec id="sec0017"><label>6.11</label><title>Artemisinin from <italic>Artemisia</italic> spp</title><p id="para0050">Artemisinin (<bold>18</bold>) (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>) is a cadinanolide endoperoxide sesquiterpene lactone originally isolated from <italic>Artemisa annua</italic> Linn in 1972 (<xref rid="bib0126" ref-type="bibr">Tu,&#x000a0;2016</xref>). Nowadays, <bold>18</bold> and their derivatives are part of the protocols for malaria treatment (<xref rid="bib0015" ref-type="bibr">Bridgford&#x000a0;et&#x000a0;al., 2018</xref>). Experimental studies have also established their effectiveness as an anti-inflammatory, antioxidant, anti-tumor, and vascular protection agent (<xref rid="bib0066" ref-type="bibr">Kim&#x000a0;et&#x000a0;al., 2015</xref>; <xref rid="bib0062" ref-type="bibr">Jiang&#x000a0;et&#x000a0;al., 2016</xref>; <xref rid="bib0036" ref-type="bibr">Efferth,&#x000a0;2017</xref>). Regarding to vascular protection, <xref rid="bib0017" ref-type="bibr">Cao&#x000a0;et&#x000a0;al. (2020</xref>) demonstrated that oral administration of artemisinin (<bold>18</bold>) effectively alleviated inflammatory response (MCP-1, IFN-&#x003b3;, IL-6 and TNF-&#x003b1;), elevated macrophage autophagy, suppressed foamy macrophage transformation, and thereby inhibiting atherosclerotic plaque formation in high-fat diet treated ApoE<sup>&#x02212;/&#x02212;</sup> mice. In addition, <bold>18</bold> has been discovered to be a potential therapeutic agent for ameliorating type 1 diabetes because of its ability to promote the conversion of pancreatic glucagon-producing &#x003b1; cells to insulin-secreting &#x003b2; cells in rats (<xref rid="bib0076" ref-type="bibr">Li&#x000a0;et&#x000a0;al., 2017</xref>). Nevertheless, the widespread application of artemisinin as an anti-malarial drug could contributed to the selection of resistant strains of the etiologic agent <italic>Plasmodium</italic>, thus its use to combating non-communicable human diseases would raise the risk for this selection and lead to an important drug resistance development. Some authors have suggested that unless necessary, artemisinin (<bold>18</bold>) should be replaced by other therapeutic agents for the treatment of versatile types of human diseases (<xref rid="bib0033" ref-type="bibr">Dong-Sheng&#x000a0;et&#x000a0;al., 2017</xref>).</p><p id="para0051">It is important to note that some species of <italic>Artemisia</italic> have been traditionally used in treatment of diabetes such as <italic>A. dracunulus</italic> L., <italic>A. minor</italic> Jacq. ex Besser, <italic>A. pallens</italic> Wall. ex D.C., <italic>A. sphaerocephala</italic> Krasch and <italic>A. herba-alba</italic> Asso, (<xref rid="bib0088" ref-type="bibr">Mohamed&#x000a0;et&#x000a0;al., 2010</xref>; <xref rid="bib0119" ref-type="bibr">Subramoniam,&#x000a0;2016</xref>). Several eudesmanolides and guaianolides have been isolated from <italic>A. herba-alba</italic>, all of them having in common the absence of the &#x003b1;-methylene in the &#x003b3;-lactone ring as in artemisinin (<bold>18</bold>) structure. Indeed the ethanol, chloroform and water extracts of this plant have showed important hypoglycemic activity (<xref rid="bib0088" ref-type="bibr">Mohamed&#x000a0;et&#x000a0;al., 2010</xref>).</p><p id="para0052">Animal experiments show considerable toxicity after the application of artemisinin family (neurotoxicity, embryotoxicity, genotoxicity, hemato- and immunotoxicity, cardiotoxicity, nephrotoxicity, and allergic reactions), but large clinical studies and meta-analyzes did not show serious human side effects, although proper monitoring of adverse effects in developing countries may not be a trivial task. There is a paucity of large-scale clinical trials adequate to detect rare but significant toxicity. The lesson learned from animal and human studies is that long-term availability rather than short-term peak concentrations of artemisinin cause toxicity (<xref rid="bib0037" ref-type="bibr">Efferth&#x000a0;and Kaina,&#x000a0;2010</xref>). Thus, the observation of the toxicity of artemisinin derivatives in animals, but not in humans, is most likely due to different pharmacokinetic profiles after different routes of administrations.</p></sec><sec id="sec0018"><label>6.12</label><title>Scoporanolide and estafiatin from <italic>Artemisia scoparia</italic> Waldst. &#x00026; Kit</title><p id="para0053">
<italic>Artemisia scoparia</italic> Waldst. &#x00026; Kit. (redstem wormwood) is widely distributed in Southwest Asia and central Europe<italic>.</italic> This species has been reported to possess anti-obesity (<xref rid="bib0103" ref-type="bibr">Richard&#x000a0;et&#x000a0;al., 2014</xref>) and hypolipidemic (<xref rid="bib0014" ref-type="bibr">Boudreau&#x000a0;et&#x000a0;al., 2018</xref>) properties. <italic>A. scoparia</italic> ethanolic extract reduces non-alcoholic fatty liver disease by enhancing hepatic insulin and AMP-AMPK signaling in diet-induced obese mice (<xref rid="bib0130" ref-type="bibr">Wang&#x000a0;et&#x000a0;al., 2013</xref>). <italic>A. scoparia</italic> hot water extract reduces blood pressure in spontaneously hypertensive rats via the inhibition of plasma angiotensin I-converting enzyme (ACE) activity (<xref rid="bib0026" ref-type="bibr">Cho&#x000a0;et&#x000a0;al., 2015</xref>). The phytochemical analysis of this extract revealed that seven SLns contribute to the antihypertensive effect inhibition of ACE activity, highlighting the activity of scoporanolide (<bold>19</bold>) and estafiatin (<bold>20</bold>) (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>) (<xref rid="bib0025" ref-type="bibr">Cho&#x000a0;et&#x000a0;al., 2016</xref>) showing significantly higher ACE inhibitory activities than the other isolated SLns. No <italic>in vivo</italic> toxicity studies on scoporanolide (<bold>19</bold>) and estafiatin (<bold>20</bold>) have been reported to date.</p></sec><sec id="sec0019"><label>6.13</label><title>Cumambrin A from <italic>Chrysanthemum boreale</italic> (Makino) Makino</title><p id="para0054">The guaianolide cumambrin A (<bold>21</bold>) (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>), isolated from <italic>Chrysanthemum boreale</italic> (Makino) Makino, has shown a pharmacological effect on the normalization of blood pressure in spontaneously hypertensive rats (<xref rid="bib0056" ref-type="bibr">Hong&#x000a0;et&#x000a0;al., 1999</xref>). <italic>Ex vivo</italic> study demonstrate that this compound is a potent relaxant of aortic smooth muscle at a concentration of 5&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;5</sup>&#x000a0;M (<xref rid="bib0057" ref-type="bibr">Hong&#x000a0;et&#x000a0;al., 2005</xref>). No <italic>in vivo</italic> toxicity studies on cumambrin A (<bold>21</bold>) have been reported to date.</p></sec></sec><sec id="sec0020"><label>7</label><title>Concluding remarks</title><p id="para0055">The potential beneficial effects of SLns on MetS&#x000b4;s risk factors discussed in this review clearly demonstrate that these substances represent remarkable compounds with a diversity of molecular structure and biological activity. These beneficial effects include normalization of blood glucose levels, improvement of blood lipid profiles, anti-inflammatory activity, improvement of insulin sensitivity and normalization of blood pressure. The underlying molecular targets mediating these effects have not been completely understood. Regardless of that, it can be noticed that at least six molecular targets or pathways could explain the effect of SLns on components of MetS: (a) inhibition of &#x003b1;-glucosidase; (b) inhibition of TLR4 signaling; (c) inhibition of NF-&#x003ba;B pathway; (d) dual PPAR&#x003b1;/&#x003b3; agonists; (e) AMPK agonist activity and (f) regeneration and revitalization of the remaining &#x003b2; cells.</p><p id="para0056">Furthermore, the evidence from published literature demonstrates that some SLns belonging to guaianolides like eremanthin (<bold>4</bold>) and germacranolides such as costunolide (<bold>5</bold>) and guaianolide dimers byrsonines A and B (<bold>14, 15</bold>), show multifunctional benefits due to their action on many MetS&#x000b4;s risk factors. These observations suggest that structural specificity may be a key for understanding the mechanisms of action of SLns. Looking forward, the effects of SLns on MetS should be explained based on the molecular targets and should be related to biochemical mechanisms. MetS has become a major public health problem worldwide and represents a common clinical condition in countries with a high incidence of obesity and western dietary patterns. Natural products, such as SLns, are attractive drug candidates and more attention must be paid to their potential use in the treatment and prevention of MetS.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="para0057">The authors declare no conflict of interest.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><name><surname>Adekenov</surname><given-names>S.M.</given-names></name></person-group><article-title>Sesquiterpene lactones with unusual structure. Their biogenesis and biological activity</article-title><source>Fitoterapia</source><volume>121</volume><year>2017</year><fpage>16</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2017.05.017</pub-id><pub-id pub-id-type="pmid">28579552</pub-id></element-citation></ref><ref id="bib0002"><element-citation publication-type="journal" id="sbref0002"><person-group person-group-type="author"><name><surname>Ajani</surname><given-names>H.B.</given-names></name><name><surname>Patel</surname><given-names>H.P.</given-names></name><name><surname>Shah</surname><given-names>G.B.</given-names></name><name><surname>Acharya</surname><given-names>S.R.</given-names></name><name><surname>Shah</surname><given-names>S.K.</given-names></name></person-group><article-title>Evaluation of antidiabetic effect of methanolic extract of <italic>Inula racemosa</italic> root in rats</article-title><source>Pharmacologyonline</source><volume>129</volume><year>2009</year><fpage>118</fpage><lpage>129</lpage></element-citation></ref><ref id="bib0003"><element-citation publication-type="journal" id="sbref0003"><person-group person-group-type="author"><name><surname>Ajao</surname><given-names>A.A.</given-names></name><name><surname>Moteetee</surname><given-names>A.N.</given-names></name></person-group><article-title><italic>Tithonia diversifolia</italic> (Hemsl) A. Gray. (Asteraceae: Heliantheae), an invasive plant of significant ethnopharmacological importance: A review</article-title><source>South African Journal of Botany</source><volume>113</volume><year>2017</year><fpage>396</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2017.09.017</pub-id></element-citation></ref><ref id="bib0004"><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>K.G.</given-names></name><name><surname>Eckel</surname><given-names>R.H.</given-names></name><name><surname>Grundy</surname><given-names>S.M.</given-names></name><name><surname>Zimmet</surname><given-names>P.Z.</given-names></name><name><surname>Cleeman</surname><given-names>J.I.</given-names></name><name><surname>Donato</surname><given-names>K.A.</given-names></name><name><surname>Fruchart</surname><given-names>J.C.</given-names></name><name><surname>James</surname><given-names>W.P.T.</given-names></name><name><surname>Loria</surname><given-names>C.M.</given-names></name><name><surname>Smith</surname><given-names>S.C.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity</article-title><source>Circulation</source><volume>120</volume><year>2009</year><fpage>1640</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.192644</pub-id><pub-id pub-id-type="pmid">19805654</pub-id></element-citation></ref><ref id="bib0005"><element-citation publication-type="book" id="sbref0005"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>M.R.</given-names></name><name><surname>Anesini</surname><given-names>C.A.</given-names></name><name><surname>Martino</surname><given-names>R.F.</given-names></name></person-group><chapter-title>Anti-inflammatory activity</chapter-title><person-group person-group-type="editor"><name><surname>S&#x000fc;lsen</surname><given-names>V.P.</given-names></name><name><surname>Martino</surname><given-names>V.S.</given-names></name></person-group><source>Sesquiterpene Lactones. Advances in Their Chemistry and Biological Aspects</source><year>2018</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><fpage>325</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-78274-4</pub-id></element-citation></ref><ref id="bib0006"><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name><surname>Al-Snafi</surname><given-names>A.E.</given-names></name></person-group><article-title>Medical importance of <italic>Cichorium intybus</italic>-A review</article-title><source>IOSR Journal of Pharmacy</source><volume>6</volume><issue>3</issue><year>2016</year><fpage>41</fpage><lpage>56</lpage><ext-link ext-link-type="uri" xlink:href="http://www.iosrphr.org/papers/v6i3/E0634156.pdf" id="interref0001">http://www.iosrphr.org/papers/v6i3/E0634156.pdf</ext-link></element-citation></ref><ref id="bib0007"><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name><surname>Andrade-Cetto</surname><given-names>A.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Mexican plants with hypoglycaemic effect used in the treatment of diabetes</article-title><source>Journal of Ethnopharmacology</source><volume>99</volume><issue>3</issue><year>2005</year><fpage>325</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.04.019</pub-id><pub-id pub-id-type="pmid">15964161</pub-id></element-citation></ref><ref id="bib0008"><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name><surname>Aybar</surname><given-names>M.J.</given-names></name><name><surname>Riera</surname><given-names>A.N.S.</given-names></name><name><surname>Grau</surname><given-names>A.</given-names></name><name><surname>Sanchez</surname><given-names>S.S.</given-names></name></person-group><article-title>Hypoglycemic effect of the water extract of <italic>Smallantus sonchifolius</italic> (yacon) leaves in normal and diabetic rats</article-title><source>Journal of Ethnopharmacology</source><volume>74</volume><issue>2</issue><year>2001</year><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(00)00351-2</pub-id><pub-id pub-id-type="pmid">11167030</pub-id></element-citation></ref><ref id="bib0009"><element-citation publication-type="journal" id="sbref0009"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>R.G.</given-names></name><name><surname>Hayden</surname><given-names>M.S.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>NF-&#x003ba;B, inflammation, and metabolic disease</article-title><source>Cell Metabolism</source><volume>13</volume><issue>1</issue><year>2011</year><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2010.12.008</pub-id><pub-id pub-id-type="pmid">21195345</pub-id></element-citation></ref><ref id="bib0010"><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Balakumar</surname><given-names>P.</given-names></name><name><surname>Mahadevan</surname><given-names>N.</given-names></name><name><surname>Sambathkumar</surname><given-names>R.</given-names></name></person-group><article-title>A contemporary overview of PPAR&#x003b1;/&#x003b3; dual agonists for the management of diabetic dyslipidemia</article-title><source>Current Molecular Pharmacology</source><volume>12</volume><issue>3</issue><year>2019</year><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.2174/1874467212666190111165015</pub-id><pub-id pub-id-type="pmid">30636619</pub-id></element-citation></ref><ref id="bib0011"><element-citation publication-type="journal" id="sbref0011"><person-group person-group-type="author"><name><surname>Baroni</surname><given-names>S.</given-names></name><name><surname>Suzuki-Kemmelmeier</surname><given-names>F.</given-names></name><name><surname>Caparroz-Assef</surname><given-names>S.M.</given-names></name><name><surname>Cuman</surname><given-names>R.K.N.</given-names></name><name><surname>Bersani-Amado</surname><given-names>C.A.</given-names></name></person-group><article-title>Effect of crude extracts of leaves of <italic>Smallanthus sonchifolius</italic> (yacon) on glycemia in diabetic rats</article-title><source>Revista Brasileira de Ci&#x000ea;ncias Farmac&#x000ea;uticas</source><volume>44</volume><issue>3</issue><year>2008</year><fpage>521</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1590/S1516-93322008000300024</pub-id></element-citation></ref><ref id="bib0012"><element-citation publication-type="journal" id="sbref0012"><person-group person-group-type="author"><name><surname>B&#x000e9;jar</surname><given-names>E.</given-names></name><name><surname>Malone</surname><given-names>M.H.</given-names></name></person-group><article-title>Pharmacological and chemical screening of <italic>Byrsonima crassifolia</italic>, a medicinal tree from Mexico. Part I</article-title><source>Journal of Ethnopharmacology</source><volume>39</volume><issue>2</issue><year>1993</year><fpage>141</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(93)90029-5</pub-id><pub-id pub-id-type="pmid">8412247</pub-id></element-citation></ref><ref id="bib0013"><element-citation publication-type="journal" id="sbref0013"><person-group person-group-type="author"><name><surname>Botta</surname><given-names>M.</given-names></name><name><surname>Audano</surname><given-names>M.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name><name><surname>Sirtori</surname><given-names>C.R.</given-names></name><name><surname>Mitro</surname><given-names>N.</given-names></name><name><surname>Ruscica</surname><given-names>M.</given-names></name></person-group><article-title>PPAR agonists and metabolic syndrome: an established role?</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><issue>4</issue><year>2018</year><fpage>1197</fpage><pub-id pub-id-type="doi">10.3390/ijms19041197</pub-id></element-citation></ref><ref id="bib0014"><element-citation publication-type="journal" id="sbref0014"><person-group person-group-type="author"><name><surname>Boudreau</surname><given-names>A.</given-names></name><name><surname>Richard</surname><given-names>A.J.</given-names></name><name><surname>Burrell</surname><given-names>J.A.</given-names></name><name><surname>King</surname><given-names>W.T.</given-names></name><name><surname>Dunn</surname><given-names>R.</given-names></name><name><surname>Schwarz</surname><given-names>J.M.</given-names></name><name><surname>Ribnicky</surname><given-names>D.M.</given-names></name><name><surname>Rood</surname><given-names>J.</given-names></name><name><surname>Salbaum</surname><given-names>J.M.</given-names></name><name><surname>Stephens</surname><given-names>J.M.</given-names></name></person-group><article-title>An ethanolic extract of <italic>Artemisia scoparia</italic> inhibits lipolysis <italic>in vivo</italic> and has antilipolytic effects on murine adipocytes <italic>in vitro</italic>. American Journal of Physiology</article-title><source>Endocrinology and Metabolism</source><volume>315</volume><issue>5</issue><year>2018</year><fpage>E1053</fpage><lpage>E1061</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00177.2018</pub-id><pub-id pub-id-type="pmid">30153067</pub-id></element-citation></ref><ref id="bib0015"><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Bridgford</surname><given-names>J.L.</given-names></name><name><surname>Xie</surname><given-names>S.C.</given-names></name><name><surname>Cobbold</surname><given-names>S.A.</given-names></name><name><surname>Pasaje</surname><given-names>C.F.A.</given-names></name><name><surname>Herrmann</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Gillett</surname><given-names>D.L.</given-names></name><name><surname>Dick</surname><given-names>L.R.</given-names></name><name><surname>Ralph</surname><given-names>S.A.</given-names></name><name><surname>Dogovski</surname><given-names>C.</given-names></name><name><surname>Spillman</surname><given-names>N.J.</given-names></name><name><surname>Tilley</surname><given-names>L.</given-names></name></person-group><article-title>Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome</article-title><source>Nature Communications</source><volume>9</volume><year>2018</year><fpage>3801</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-06221-1</pub-id></element-citation></ref><ref id="bib0016"><element-citation publication-type="journal" id="sbref0016"><person-group person-group-type="author"><name><surname>Caetano</surname><given-names>B.F.R.</given-names></name><name><surname>De Moura</surname><given-names>N.A.</given-names></name><name><surname>Almeida</surname><given-names>A.P.S.</given-names></name><name><surname>Dias</surname><given-names>M.C.</given-names></name><name><surname>Sivieri</surname><given-names>K.</given-names></name><name><surname>Barbisan</surname><given-names>L.F.</given-names></name></person-group><article-title>Yacon (<italic>Smallanthus sonchifolius</italic>) as a food supplement: health-promoting benefits of fructooligosaccharides</article-title><source>Nutrients</source><volume>8</volume><issue>7</issue><year>2016</year><fpage>436</fpage><pub-id pub-id-type="doi">10.3390/nu8070436</pub-id></element-citation></ref><ref id="bib0017"><element-citation publication-type="journal" id="sbref0017"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Q.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Duan</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Artemisinin attenuated atherosclerosis in high-fat diet-fed ApoE-/- mice by promoting macrophage autophagy through the AMPK/mTOR/ULK1 pathway</article-title><source>Journal of Cardiovascular Pharmacology</source><volume>75</volume><issue>4</issue><year>2020</year><fpage>321</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1097/FJC.0000000000000794</pub-id><pub-id pub-id-type="pmid">31895870</pub-id></element-citation></ref><ref id="bib0018"><element-citation publication-type="journal" id="sbref0018"><person-group person-group-type="author"><name><surname>Casta&#x000f1;eda-Acosta</surname><given-names>J.</given-names></name><name><surname>Fischer</surname><given-names>N.H.</given-names></name><name><surname>Vargas</surname><given-names>D.</given-names></name></person-group><article-title>Biomimetic transformations of parthenolide</article-title><source>Journal of Natural Products</source><volume>56</volume><issue>1</issue><year>1993</year><fpage>90</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1021/np50091a013</pub-id><pub-id pub-id-type="pmid">8450324</pub-id></element-citation></ref><ref id="bib0019"><element-citation publication-type="journal" id="sbref0019"><person-group person-group-type="author"><name><surname>Catrysse</surname><given-names>L.</given-names></name><name><surname>van Loo</surname><given-names>G.</given-names></name></person-group><article-title>Inflammation and the metabolic syndrome: the tissue-specific functions of NF-&#x003ba;B</article-title><source>Trends in Cell Biology</source><volume>27</volume><issue>6</issue><year>2017</year><fpage>417</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2017.01.006</pub-id><pub-id pub-id-type="pmid">28237661</pub-id></element-citation></ref><ref id="bib0020"><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Cavin</surname><given-names>C.</given-names></name><name><surname>Delannoy</surname><given-names>M.</given-names></name><name><surname>Malnoe</surname><given-names>A.</given-names></name><name><surname>Debefve</surname><given-names>E.</given-names></name><name><surname>Touch&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Courtois</surname><given-names>D.</given-names></name><name><surname>Schilter</surname><given-names>B.</given-names></name></person-group><article-title>Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract</article-title><source>Biochemical and Biophysical Research Communications</source><volume>327</volume><issue>3</issue><year>2005</year><fpage>742</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.061</pub-id><pub-id pub-id-type="pmid">15649409</pub-id></element-citation></ref><ref id="bib0021"><element-citation publication-type="journal" id="sbref0021"><person-group person-group-type="author"><name><surname>Chadwick</surname><given-names>M.</given-names></name><name><surname>Trewin</surname><given-names>H.</given-names></name><name><surname>Gawthrop</surname><given-names>F.</given-names></name><name><surname>Wagstaff</surname><given-names>C.</given-names></name></person-group><article-title>Sesquiterpenoids lactones: benefits to plants and people</article-title><source>International Journal of Molecular Sciences</source><volume>14</volume><issue>6</issue><year>2013</year><fpage>12780</fpage><lpage>12805</lpage><pub-id pub-id-type="doi">10.3390/ijms140612780</pub-id><pub-id pub-id-type="pmid">23783276</pub-id></element-citation></ref><ref id="bib0022"><mixed-citation publication-type="other" id="sbref0022">Chandra, K., Sk, J., 2016. Therapeutic potential of <italic>Cichorium Intybus</italic> in lifestyle disorders: a review. 9(3). <ext-link ext-link-type="uri" xlink:href="https://innovareacademics.in/journals/index.php/ajpcr/article/view/11268" id="interref0002">https://innovareacademics.in/journals/index.php/ajpcr/article/view/11268</ext-link></mixed-citation></ref><ref id="bib0023"><element-citation publication-type="book" id="sbref0023"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>D.</given-names></name></person-group><chapter-title>Sesquiterpene lactones: structural diversity and their biological activities</chapter-title><person-group person-group-type="editor"><name><surname>Tiwari</surname><given-names>V.K.</given-names></name><name><surname>Mishra</surname><given-names>B.B.</given-names></name></person-group><source>Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry</source><year>2011</year><publisher-name>Research Signpost</publisher-name><publisher-loc>Kerala</publisher-loc><fpage>313</fpage><lpage>334</lpage></element-citation></ref><ref id="bib0024"><element-citation publication-type="book" id="sbref0024"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>D.</given-names></name><name><surname>Dwivedi</surname><given-names>P.K.</given-names></name></person-group><chapter-title>Recent developments on the antidiabetic sesquiterpene lactones and their semisynthetic analogues</chapter-title><person-group person-group-type="editor"><name><surname>Brahmachari</surname><given-names>G.</given-names></name></person-group><source>Discovery and Development of Antidiabetic Agents from Natural Products: Natural Product Drug Discovery</source><year>2016</year><publisher-name>Elsevier</publisher-name><fpage>185</fpage><lpage>208</lpage></element-citation></ref><ref id="bib0025"><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.Y.</given-names></name><name><surname>Jeong</surname><given-names>S.J</given-names></name><name><surname>Lee</surname><given-names>H.L.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Hwang</surname><given-names>D.Y.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>Y.G.</given-names></name><name><surname>Moon</surname><given-names>J.H.</given-names></name><name><surname>Ham</surname><given-names>K.S.</given-names></name></person-group><article-title>Sesquiterpene lactones and scopoletins from <italic>Artemisia scoparia</italic> Waldst. &#x00026; Kit. and their angiotensin I-converting enzyme inhibitory activities</article-title><source>Food Science and Biotechnology</source><volume>25</volume><issue>6</issue><year>2016</year><fpage>1701</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1007/s10068-016-0261-x</pub-id><pub-id pub-id-type="pmid">30263465</pub-id></element-citation></ref><ref id="bib0026"><element-citation publication-type="journal" id="sbref0026"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.Y.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Hwang</surname><given-names>D.Y.</given-names></name><name><surname>Chanmuang</surname><given-names>S.</given-names></name><name><surname>Jaiswal</surname><given-names>L.</given-names></name><name><surname>Park</surname><given-names>Y.K.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>H.R.</given-names></name><name><surname>Moon</surname><given-names>J.H.</given-names></name><name><surname>Ham</surname><given-names>K.S.</given-names></name></person-group><article-title>Antihypertensive effects of <italic>Artemisia scoparia</italic> waldst in spontaneously hypertensive rats and identification of Angiotensin I converting enzyme inhibitors</article-title><source>Molecules</source><volume>20</volume><issue>11</issue><year>2015</year><fpage>19789</fpage><lpage>19804</lpage><pub-id pub-id-type="doi">10.3390/molecules201119657</pub-id><pub-id pub-id-type="pmid">26540035</pub-id></element-citation></ref><ref id="bib0027"><element-citation publication-type="journal" id="sbref0027"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>R.J.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>D.S.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name><name><surname>Nam</surname><given-names>Y.J.</given-names></name><name><surname>Lee</surname><given-names>D.U.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name></person-group><article-title>Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-&#x003ba;B, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells</article-title><source>International Immunopharmacology</source><volume>14</volume><issue>4</issue><year>2012</year><fpage>375</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2012.08.011</pub-id><pub-id pub-id-type="pmid">22940184</pub-id></element-citation></ref><ref id="bib0028"><element-citation publication-type="journal" id="sbref0028"><person-group person-group-type="author"><name><surname>Cicero</surname><given-names>A.F.</given-names></name><name><surname>Colletti</surname><given-names>A.</given-names></name></person-group><article-title>Role of phytochemicals in the management of metabolic syndrome</article-title><source>Phytomedicine</source><volume>23</volume><issue>11</issue><year>2016</year><fpage>1134</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2015.11.009</pub-id><pub-id pub-id-type="pmid">26778479</pub-id></element-citation></ref><ref id="bib0029"><element-citation publication-type="journal" id="sbref0029"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>F.F.</given-names></name><name><surname>Ros&#x000e1;rio</surname><given-names>W.R.</given-names></name><name><surname>Ribeiro-Farias</surname><given-names>A.C.</given-names></name><name><surname>de Souza</surname><given-names>R.G.</given-names></name><name><surname>Duarte-Gondim</surname><given-names>R.S.</given-names></name><name><surname>Barroso</surname><given-names>W.A.</given-names></name></person-group><article-title>Metabolic syndrome and COVID-19: an update on the associated comorbidities and proposed therapies</article-title><source>Diabetes &#x00026; Metabolic Syndrome: Clinical Research &#x00026; Reviews</source><volume>14</volume><issue>5</issue><year>2020</year><fpage>809</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1016/j.dsx.2020.06.016</pub-id></element-citation></ref><ref id="bib0030"><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Daisy</surname><given-names>P.</given-names></name><name><surname>Eliza</surname><given-names>J.</given-names></name><name><surname>Ignacimuthu</surname><given-names>S.</given-names></name></person-group><article-title>Influence of <italic>Costus speciosus</italic> (Koen.) Sm. Rhizome extracts on biochemical parameters in streptozotocin induced diabetic rats</article-title><source>Journal of Health Science</source><volume>54</volume><issue>6</issue><year>2008</year><fpage>675</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1248/jhs.54.675</pub-id></element-citation></ref><ref id="bib0031"><element-citation publication-type="journal" id="sbref0031"><person-group person-group-type="author"><name><surname>De Pedro</surname><given-names>A.</given-names></name><name><surname>Cuenca</surname><given-names>M.D.R.</given-names></name><name><surname>Grau</surname><given-names>A.</given-names></name><name><surname>Catal&#x000e1;n</surname><given-names>C.A.N.</given-names></name><name><surname>Gedris</surname><given-names>T.E.</given-names></name><name><surname>Herz</surname><given-names>W.</given-names></name></person-group><article-title>Melampolides from <italic>Smallanthus macroscyphus</italic></article-title><source>Biochemical Systematics and Ecology</source><volume>31</volume><issue>9</issue><year>2003</year><fpage>1067</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1016/S0305-1978(03)00064-4</pub-id></element-citation></ref><ref id="bib0032"><element-citation publication-type="journal" id="sbref0032"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>G.T.C.</given-names></name><name><surname>Tamashiro</surname><given-names>W.M.D.S.C.</given-names></name><name><surname>Junior</surname><given-names>M.R.M.</given-names></name><name><surname>Pastore</surname><given-names>G.M.</given-names></name></person-group><article-title>Yacon (<italic>Smallanthus sonchifolius</italic>): a functional food</article-title><source>Plant Foods for Human Nutrition</source><volume>68</volume><year>2013</year><fpage>222</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1007/s11130-013-0362-0</pub-id><pub-id pub-id-type="pmid">23709016</pub-id></element-citation></ref><ref id="bib0033"><element-citation publication-type="journal" id="sbref0033"><person-group person-group-type="author"><name><surname>Dong-Sheng</surname><given-names>Y.</given-names></name><name><surname>Yan-Ping</surname><given-names>C.</given-names></name><name><surname>Li-Li</surname><given-names>T.</given-names></name><name><surname>Shui-Qing</surname><given-names>H.</given-names></name><name><surname>Chang-Qing</surname><given-names>L.</given-names></name><name><surname>Qi</surname><given-names>W.</given-names></name><name><surname>Qing-Ping</surname><given-names>Z.</given-names></name></person-group><article-title>Artemisinin: A panacea eligible for unrestrictive use?</article-title><source>Frontiers in Pharmacology</source><volume>8</volume><year>2017</year><fpage>737</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00737</pub-id><pub-id pub-id-type="pmid">29089893</pub-id></element-citation></ref><ref id="bib0034"><element-citation publication-type="book" id="sbref0034"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>O.</given-names></name></person-group><chapter-title>Nance (<italic>Byrsonima crassifolia</italic> (L.) Kunth)</chapter-title><person-group person-group-type="editor"><name><surname>Yahia</surname><given-names>E.M.</given-names></name></person-group><series>Postharvest Biology and Technology of Tropical and Subtropical Fruits</series><volume>4</volume><year>2011</year><publisher-name>Woodhead Publishing</publisher-name><fpage>44</fpage><lpage>52e</lpage><pub-id pub-id-type="doi">10.1533/9780857092618.44</pub-id></element-citation></ref><ref id="bib0035"><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Eddouks</surname><given-names>M.</given-names></name><name><surname>Maghrani</surname><given-names>M.</given-names></name><name><surname>Lemhadri</surname><given-names>A.</given-names></name><name><surname>Ouahidi</surname><given-names>M.-.L.</given-names></name><name><surname>Jouad</surname><given-names>H.</given-names></name></person-group><article-title>Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet)</article-title><source>Journal of Ethnopharmacology</source><volume>82</volume><issue>2&#x02013;3</issue><year>2002</year><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(02)00164-2</pub-id><pub-id pub-id-type="pmid">12241983</pub-id></element-citation></ref><ref id="bib0036"><element-citation publication-type="journal" id="sbref0036"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>From ancient herb to modern drug: <italic>Artemisia annua</italic> and artemisinin for cancer therapy</article-title><source>Seminars in Cancer Biology</source><volume>46</volume><year>2017</year><fpage>65</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2017.02.009</pub-id><pub-id pub-id-type="pmid">28254675</pub-id></element-citation></ref><ref id="bib0037"><element-citation publication-type="journal" id="sbref0037"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Kaina</surname><given-names>B.</given-names></name></person-group><article-title>Toxicity of the antimalarial artemisinin and its dervatives</article-title><source>Critical Reviews in Toxicology</source><volume>40</volume><issue>5</issue><year>2010</year><fpage>405</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.3109/10408441003610571</pub-id><pub-id pub-id-type="pmid">20158370</pub-id></element-citation></ref><ref id="bib0038"><element-citation publication-type="journal" id="sbref0038"><person-group person-group-type="author"><name><surname>Eliza</surname><given-names>J.</given-names></name><name><surname>Daisy</surname><given-names>P.</given-names></name><name><surname>Ignacimuthu</surname><given-names>S.</given-names></name></person-group><article-title>Antioxidant activity of costunolide and eremanthin isolated from <italic>Costus speciosus</italic> (Koen ex. Retz) Sm</article-title><source>Chemico-Biological Interactions</source><volume>188</volume><year>2010</year><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2010.08.002</pub-id><pub-id pub-id-type="pmid">20709041</pub-id></element-citation></ref><ref id="bib0039"><element-citation publication-type="journal" id="sbref0039"><person-group person-group-type="author"><name><surname>Eliza</surname><given-names>J.</given-names></name><name><surname>Daisy</surname><given-names>P.</given-names></name><name><surname>Ignacimuthu</surname><given-names>S.</given-names></name><name><surname>Duraipandiyan</surname><given-names>V.</given-names></name></person-group><article-title>Normo-glycemic and hypolipidemic effect of costunolide isolated from <italic>Costus speciosus</italic> (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats</article-title><source>Chemico-Biological Interactions</source><volume>179</volume><issue>2-3</issue><year>2009</year><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2008.10.017</pub-id><pub-id pub-id-type="pmid">19007766</pub-id></element-citation></ref><ref id="bib0040"><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Eliza</surname><given-names>J.</given-names></name><name><surname>Daisy</surname><given-names>P.</given-names></name><name><surname>Ignacimuthu</surname><given-names>S.</given-names></name><name><surname>Duraipandiyan</surname><given-names>V.</given-names></name></person-group><article-title>Antidiabetic and antilipidemic effect of eremanthin from <italic>Costus speciosus</italic> (Koen.) Sm., in STZ-induced diabetic rats</article-title><source>Chemico-Biological Interactions</source><volume>182</volume><year>2009</year><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2009.08.012</pub-id><pub-id pub-id-type="pmid">19695236</pub-id></element-citation></ref><ref id="bib0041"><element-citation publication-type="book" id="sbref0041"><person-group person-group-type="author"><name><surname>Engin</surname><given-names>A.</given-names></name></person-group><chapter-title>The definition and prevalence of obesity and metabolic syndrome</chapter-title><person-group person-group-type="editor"><name><surname>Engin</surname><given-names>A.B.</given-names></name><name><surname>Engin</surname><given-names>A.</given-names></name></person-group><series>Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology</series><volume>960</volume><year>2017</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-48382-5_1</pub-id></element-citation></ref><ref id="bib0042"><element-citation publication-type="journal" id="sbref0042"><person-group person-group-type="author"><name><surname>Feltenstein</surname><given-names>M.W.</given-names></name><name><surname>Sch&#x000fc;hly</surname><given-names>W.</given-names></name><name><surname>Warnick</surname><given-names>J.E.</given-names></name><name><surname>Fischer</surname><given-names>N.H.</given-names></name><name><surname>Sufka</surname><given-names>K.J.</given-names></name></person-group><article-title>Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear's foot</article-title><source>Pharmacology Biochemistry and Behavior</source><volume>79</volume><issue>2</issue><year>2004</year><fpage>299</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2004.08.008</pub-id></element-citation></ref><ref id="bib0043"><element-citation publication-type="journal" id="sbref0043"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Ou</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Ji</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name></person-group><article-title>The role of JNk signaling pathway in obesity-driven insulin resistance</article-title><source>Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy</source><volume>13</volume><year>2020</year><fpage>1399</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S236127</pub-id></element-citation></ref><ref id="bib0044"><element-citation publication-type="book" id="sbref0044"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>N.H.</given-names></name></person-group><chapter-title>Sesquiterpene lactones: biogenesis and biomimetic transformations</chapter-title><person-group person-group-type="editor"><name><surname>Towers</surname><given-names>G.H.N.</given-names></name><name><surname>Stafford</surname><given-names>H.A.</given-names></name></person-group><source>Biochemistry of the Mevalonic Acid Pathway to Terpenoids</source><year>1990</year><publisher-name>Springer</publisher-name><publisher-loc>Boston, MA</publisher-loc><fpage>161</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1007/978-1-4684-8789-3_4</pub-id></element-citation></ref><ref id="bib0045"><element-citation publication-type="book" id="sbref0045"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>N.H.</given-names></name><name><surname>Olivier</surname><given-names>E.J.</given-names></name><name><surname>Fischer</surname><given-names>H.D.</given-names></name></person-group><chapter-title>The biogenesis and chemistry of sesquiterpene lactones</chapter-title><person-group person-group-type="editor"><name><surname>Herz</surname><given-names>W.</given-names></name><name><surname>Grisebach</surname><given-names>H.</given-names></name><name><surname>Kirby</surname><given-names>G.W.</given-names></name></person-group><series>Fortschritte Der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products</series><volume>38</volume><year>1979</year><publisher-name>Springer</publisher-name><publisher-loc>Vienna</publisher-loc><fpage>47</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1007/978-3-7091-8548-3_2</pub-id></element-citation></ref><ref id="bib0046"><element-citation publication-type="journal" id="sbref0046"><person-group person-group-type="author"><name><surname>Francini-Pesenti</surname><given-names>F.</given-names></name><name><surname>Spinella</surname><given-names>P.</given-names></name><name><surname>Cal&#x000f2;</surname><given-names>L.A.</given-names></name></person-group><article-title>Potential role of phytochemicals in metabolic syndrome prevention and therapy</article-title><source>Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy</source><volume>12</volume><year>2019</year><fpage>1987</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S214550</pub-id></element-citation></ref><ref id="bib0047"><element-citation publication-type="journal" id="sbref0047"><person-group person-group-type="author"><name><surname>Genta</surname><given-names>S.B.</given-names></name><name><surname>Cabrera</surname><given-names>W.M.</given-names></name><name><surname>Mercado</surname><given-names>M.I.</given-names></name><name><surname>Grau</surname><given-names>A.</given-names></name><name><surname>Catal&#x000e1;n</surname><given-names>C.A.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>S.S.</given-names></name></person-group><article-title>Hypoglycemic activity of leaf organic extracts from <italic>Smallanthus sonchifolius</italic>: constituents of the most active fractions</article-title><source>Chemico-Biological Interactions</source><volume>185</volume><year>2010</year><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2010.03.004</pub-id><pub-id pub-id-type="pmid">20211156</pub-id></element-citation></ref><ref id="bib0048"><element-citation publication-type="journal" id="sbref0048"><person-group person-group-type="author"><name><surname>Gomez-Hernandez</surname><given-names>A.</given-names></name><name><surname>Beneit</surname><given-names>N.</given-names></name><name><surname>Diaz-Castroverde</surname><given-names>S.</given-names></name><name><surname>Escribano</surname><given-names>O.</given-names></name></person-group><article-title>Differential role of adipose tissues in obesity and related metabolic and vascular complications</article-title><source>International Journal of Endocrinology</source><volume>2016</volume><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/1216783</pub-id></element-citation></ref><ref id="bib0049"><element-citation publication-type="journal" id="sbref0049"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Xue</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Ge</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Cai</surname><given-names>D.</given-names></name><name><surname>Shan</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis</article-title><source>Frontiers in Oncology</source><volume>9</volume><year>2019</year><fpage>993</fpage><pub-id pub-id-type="doi">10.3389/fonc.2019.00993</pub-id><pub-id pub-id-type="pmid">31632919</pub-id></element-citation></ref><ref id="bib0050"><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Jom</surname><given-names>K.N.</given-names></name></person-group><article-title>A review of phytochemistry, metabolite changes, and medicinal uses of the common sunflower seed and sprouts (<italic>Helianthus annuus</italic> L.)</article-title><source>Chemistry Central Journal</source><volume>11</volume><year>2017</year><fpage>95</fpage><pub-id pub-id-type="doi">10.1186/s13065-017-0328-7</pub-id><pub-id pub-id-type="pmid">29086881</pub-id></element-citation></ref><ref id="bib0051"><element-citation publication-type="journal" id="sbref0051"><person-group person-group-type="author"><name><surname>Guti&#x000e9;rrez</surname><given-names>R.M.P.</given-names></name><name><surname>Ramirez</surname><given-names>A.M.</given-names></name></person-group><article-title>Hypoglycemic Effects of sesquiterpene lactones from <italic>Byrsonima crassifolia</italic></article-title><source>Food Science and Biotechnology</source><volume>25</volume><issue>4</issue><year>2016</year><fpage>1135</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1007/s10068-016-0182-8</pub-id><pub-id pub-id-type="pmid">30263386</pub-id></element-citation></ref><ref id="bib0052"><element-citation publication-type="journal" id="sbref0052"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>N.C.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.M.</given-names></name><name><surname>Genta</surname><given-names>S.B.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>S.S.</given-names></name></person-group><article-title>Hypolipidemic effect of <italic>Smallanthus sonchifolius</italic> (yacon) roots on diabetic rats: biochemical approach</article-title><source>Chemico-Biological Interactions</source><volume>194</volume><year>2011</year><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2011.08.009</pub-id><pub-id pub-id-type="pmid">21907189</pub-id></element-citation></ref><ref id="bib0053"><element-citation publication-type="journal" id="sbref0053"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J.W.</given-names></name><name><surname>Lee</surname><given-names>B.G.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><name><surname>Yoon</surname><given-names>J.W.</given-names></name><name><surname>Jin</surname><given-names>H.K.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>H.Y.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name><name><surname>Lee</surname><given-names>H.W.</given-names></name></person-group><article-title>Ergolide, sesquiterpene lactone from <italic>Inula britannica</italic>, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-&#x003ba;B</article-title><source>British Journal of Pharmacology</source><volume>133</volume><issue>4</issue><year>2001</year><fpage>503</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0704099</pub-id><pub-id pub-id-type="pmid">11399667</pub-id></element-citation></ref><ref id="bib0054"><element-citation publication-type="journal" id="sbref0054"><person-group person-group-type="author"><name><surname>Han</surname><given-names>M.S.</given-names></name><name><surname>White</surname><given-names>A.</given-names></name><name><surname>Perry</surname><given-names>R.J.</given-names></name><name><surname>Camporez</surname><given-names>J.P.</given-names></name><name><surname>Hidalgo</surname><given-names>J.</given-names></name><name><surname>Shulman</surname><given-names>G.I.</given-names></name><name><surname>Davis</surname><given-names>R.J.</given-names></name></person-group><article-title>Regulation of adipose tissue inflammation by interleukin 6</article-title><source>Proceedings of the National Academy of Sciences</source><volume>117</volume><issue>6</issue><year>2020</year><fpage>2751</fpage><lpage>2760</lpage><pub-id pub-id-type="doi">10.1073/pnas.1920004117</pub-id></element-citation></ref><ref id="bib0055"><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.F.</given-names></name><name><surname>Cao</surname><given-names>G.X.</given-names></name><name><surname>Gao</surname><given-names>X.J.</given-names></name><name><surname>Xia</surname><given-names>M.</given-names></name></person-group><article-title>Isolation and characterisation of the sesquiterpene lactones from <italic>Lactuca sativa</italic> L var. anagustata</article-title><source>Food Chemistry</source><volume>120</volume><issue>4</issue><year>2010</year><fpage>1083</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.11.056</pub-id></element-citation></ref><ref id="bib0056"><element-citation publication-type="journal" id="sbref0056"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y.G.</given-names></name><name><surname>Yang</surname><given-names>M.S.</given-names></name><name><surname>Pak</surname><given-names>Y.B.</given-names></name></person-group><article-title>Effect of Cumambrin A treatment on blood pressure in spontaneously hypertensive rats</article-title><source>Korean Journal of Pharmacognosy</source><volume>30</volume><issue>2</issue><year>1999</year><fpage>226</fpage><lpage>230</lpage><ext-link ext-link-type="uri" xlink:href="http://kpubs.org/article/articleMain.kpubs?articleANo=HKSOBF_1999_v30n2_226" id="interref0003">http://kpubs.org/article/articleMain.kpubs?articleANo=HKSOBF_1999_v30n2_226</ext-link></element-citation></ref><ref id="bib0057"><element-citation publication-type="journal" id="sbref0057"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y.G.</given-names></name><name><surname>Yang</surname><given-names>M.S.</given-names></name><name><surname>Pak</surname><given-names>Y.B.</given-names></name></person-group><article-title>Effect of Cumambrin A on the relaxation of rat aorta</article-title><source>Korean Journal of Pharmacognosy</source><volume>36</volume><issue>1</issue><year>2005</year><fpage>17</fpage><lpage>20</lpage><ext-link ext-link-type="uri" xlink:href="http://kpubs.org/article/articleMain.kpubs?articleANo=HKSOBF_2005_v36n1s140_17" id="interref0004">http://kpubs.org/article/articleMain.kpubs?articleANo=HKSOBF_2005_v36n1s140_17</ext-link></element-citation></ref><ref id="bib0058"><element-citation publication-type="journal" id="sbref0058"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>C.C.</given-names></name><name><surname>Lin</surname><given-names>S.J.</given-names></name><name><surname>Cheng</surname><given-names>J.T.</given-names></name><name><surname>Hsu</surname><given-names>F.L.</given-names></name></person-group><article-title>Antidiabetic dimeric guianolides and a lignan glycoside from <italic>Lactuca indica</italic></article-title><source>Journal of Natural Products</source><volume>66</volume><issue>5</issue><year>2003</year><fpage>625</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1021/np0205349</pub-id><ext-link ext-link-type="uri" xlink:href="https://pharmacologyonline.silae.it/files/archives/2009/vol3/013.HARESH.pdf" id="interref0005">https://pharmacologyonline.silae.it/files/archives/2009/vol3/013.HARESH.pdf</ext-link><pub-id pub-id-type="pmid">12762795</pub-id></element-citation></ref><ref id="bib0059"><element-citation publication-type="journal" id="sbref0059"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Al Qarni</surname><given-names>A.</given-names></name><name><surname>Hawwari</surname><given-names>A.</given-names></name><name><surname>Alghanem</surname><given-names>A.F.</given-names></name><name><surname>Ahmed</surname><given-names>G.</given-names></name></person-group><article-title>Metabolic syndrome, dyslipidemia and regulation of lipoprotein metabolism</article-title><source>Current Diabetes Reviews</source><volume>14</volume><issue>5</issue><year>2018</year><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.2174/1573399813666170705161039</pub-id><pub-id pub-id-type="pmid">28677496</pub-id></element-citation></ref><ref id="bib0060"><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Ivanescu</surname><given-names>B.</given-names></name><name><surname>Miron</surname><given-names>A.</given-names></name><name><surname>Corciova</surname><given-names>A.</given-names></name></person-group><article-title>Sesquiterpene lactones from Artemisia genus: biological activities and methods of analysis</article-title><source>Journal of Analytical Methods in Chemistry</source><volume>2015</volume><year>2015</year><pub-id pub-id-type="doi">10.1155/2015/247685</pub-id></element-citation></ref><ref id="bib0061"><element-citation publication-type="journal" id="sbref0061"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Q.Q.</given-names></name><name><surname>Wang</surname><given-names>J.C.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.J.</given-names></name><name><surname>Zhai</surname><given-names>J.D.</given-names></name><name><surname>Wei</surname><given-names>L.B.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Long</surname><given-names>H.B.</given-names></name></person-group><article-title>Sesquiterpene lactones and their derivatives inhibit high glucose-induced NF-&#x003ba;B activation and MCP-1 and TGF-&#x003b2;1 expression in rat mesangial cells</article-title><source>Molecules</source><volume>18</volume><issue>10</issue><year>2013</year><fpage>13061</fpage><lpage>13077</lpage><pub-id pub-id-type="doi">10.3390/molecules181013061</pub-id><pub-id pub-id-type="pmid">24152676</pub-id></element-citation></ref><ref id="bib0062"><element-citation publication-type="journal" id="sbref0062"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Cen</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Qin</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name></person-group><article-title>Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines</article-title><source>Phytomedicine</source><volume>23</volume><issue>11</issue><year>2016</year><fpage>1259</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2016.06.004</pub-id><pub-id pub-id-type="pmid">27316397</pub-id></element-citation></ref><ref id="bib0063"><element-citation publication-type="journal" id="sbref0063"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>T.</given-names></name><name><surname>Singh</surname><given-names>A.K.</given-names></name><name><surname>Haratipour</surname><given-names>P.</given-names></name><name><surname>Sah</surname><given-names>A.N.</given-names></name><name><surname>Pandey</surname><given-names>A.K.</given-names></name><name><surname>Naseri</surname><given-names>R.</given-names></name><name><surname>Juyal</surname><given-names>V.</given-names></name><name><surname>Farzaei</surname><given-names>M.H.</given-names></name></person-group><article-title>Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications</article-title><source>Journal of Cellular Physiology</source><volume>234</volume><issue>10</issue><year>2019</year><fpage>17212</fpage><lpage>17231</lpage><pub-id pub-id-type="doi">10.1002/jcp.28528</pub-id><pub-id pub-id-type="pmid">30916407</pub-id></element-citation></ref><ref id="bib0064"><element-citation publication-type="journal" id="sbref0064"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Kim</surname><given-names>D.H.</given-names></name></person-group><article-title>Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: a meta-analysis of prospective cohort studies</article-title><source>Medicine</source><volume>96</volume><issue>45</issue><year>2017</year><pub-id pub-id-type="doi">10.1097/MD.0000000000008491</pub-id></element-citation></ref><ref id="bib0065"><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.</given-names></name><name><surname>Yi</surname><given-names>F.</given-names></name><name><surname>Rasu</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Ma</surname><given-names>T.</given-names></name></person-group><article-title>Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction</article-title><source>IUBMB Life</source><volume>64</volume><issue>9</issue><year>2012</year><fpage>783</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1002/iub.1068</pub-id><pub-id pub-id-type="pmid">22837216</pub-id></element-citation></ref><ref id="bib0066"><element-citation publication-type="journal" id="sbref0066"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>W.S.</given-names></name><name><surname>Choi</surname><given-names>W.J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>W.J.</given-names></name><name><surname>Lee</surname><given-names>D.C.</given-names></name><name><surname>Sohn</surname><given-names>U.D.</given-names></name><name><surname>Shin</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>W.</given-names></name></person-group><article-title>Anti-inflammatory, antioxidant and antimicrobial effects of artemisinin extracts from <italic>Artemisia annua</italic> L</article-title><source>Korean Journal of Physiology &#x00026; Pharmacology</source><volume>19</volume><issue>1</issue><year>2015</year><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.4196/kjpp.2015.19.1.21</pub-id><pub-id pub-id-type="pmid">25605993</pub-id></element-citation></ref><ref id="bib0067"><element-citation publication-type="journal" id="sbref0067"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name></person-group><article-title>Alantolactone improves palmitate-induced glucose intolerance and inflammation in both lean and obese states in vitro: Adipocyte and adipocyte-macrophage co-culture system</article-title><source>International Immunopharmacology</source><volume>49</volume><year>2017</year><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2017.05.037</pub-id><pub-id pub-id-type="pmid">28599253</pub-id></element-citation></ref><ref id="bib0068"><element-citation publication-type="journal" id="sbref0068"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name></person-group><article-title>Alantolactone improves prolonged exposure of interleukin-6-induced skeletal muscle inflammation associated glucose intolerance and insulin resistance</article-title><source>Frontiers in Pharmacology</source><volume>8</volume><year>2017</year><fpage>405</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00405</pub-id><pub-id pub-id-type="pmid">28706484</pub-id></element-citation></ref><ref id="bib0069"><element-citation publication-type="journal" id="sbref0069"><person-group person-group-type="author"><name><surname>Kisiel</surname><given-names>W.</given-names></name><name><surname>Gromek</surname><given-names>D.</given-names></name></person-group><article-title>Sesquiterpene lactones from <italic>Lactuca saligna</italic></article-title><source>Phytochemistry</source><volume>34</volume><issue>6</issue><year>1993</year><fpage>1644</fpage><lpage>1646</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)90864-1</pub-id></element-citation></ref><ref id="bib0070"><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Kl&#x000f6;ting</surname><given-names>N.</given-names></name><name><surname>Bl&#x000fc;her</surname><given-names>M.</given-names></name></person-group><article-title>Adipocyte dysfunction, inflammation and metabolic syndrome</article-title><source>Reviews in Endocrine and Metabolic Disorders</source><volume>15</volume><issue>4</issue><year>2014</year><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/s11154-014-9301-0</pub-id><pub-id pub-id-type="pmid">25344447</pub-id></element-citation></ref><ref id="bib0071"><element-citation publication-type="journal" id="sbref0071"><person-group person-group-type="author"><name><surname>Knab</surname><given-names>L.M.</given-names></name><name><surname>Grippo</surname><given-names>P.J.</given-names></name><name><surname>Bentrem</surname><given-names>D.J.</given-names></name></person-group><article-title>Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase</article-title><source>World Journal of Gastroenterology</source><volume>20</volume><year>2014</year><fpage>10729</fpage><lpage>10739</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i31.10729</pub-id><pub-id pub-id-type="pmid">25152576</pub-id></element-citation></ref><ref id="bib0072"><element-citation publication-type="journal" id="sbref0072"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Song</surname><given-names>Q.H.</given-names></name><name><surname>Hong</surname><given-names>T.</given-names></name><name><surname>Kitamura</surname><given-names>H.</given-names></name><name><surname>Cyong</surname><given-names>J.C.</given-names></name></person-group><article-title>Preventative effects of the flowers of <italic>Inula britannica</italic> on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin</article-title><source>Phytotherapy Research</source><volume>16</volume><issue>4</issue><year>2002</year><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1002/ptr.868</pub-id><pub-id pub-id-type="pmid">12112297</pub-id></element-citation></ref><ref id="bib0073"><element-citation publication-type="journal" id="sbref0073"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>T.H.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Park</surname><given-names>Y.J.</given-names></name><name><surname>Hong</surname><given-names>Y.S.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>K.W.</given-names></name><name><surname>Lee</surname><given-names>J.J.</given-names></name></person-group><article-title>A sesquiterpene lactone, costunolide, from <italic>Magnolia grandiflora</italic> inhibits NF-&#x003ba;B by targeting I&#x003ba;B phosphorylation</article-title><source>Planta Medica</source><volume>67</volume><issue>02</issue><year>2001</year><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1055/s-2001-11503</pub-id><pub-id pub-id-type="pmid">11301852</pub-id></element-citation></ref><ref id="bib0074"><element-citation publication-type="journal" id="sbref0074"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>J.R.</given-names></name><name><surname>Dima</surname><given-names>L.</given-names></name><name><surname>Correll</surname><given-names>C.U.</given-names></name><name><surname>Manu</surname><given-names>P.</given-names></name></person-group><article-title>The pharmacological management of metabolic syndrome</article-title><source>Expert Review of Clinical Pharmacology</source><volume>11</volume><issue>4</issue><year>2018</year><fpage>397</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1080/17512433.2018.1429910</pub-id><pub-id pub-id-type="pmid">29345505</pub-id></element-citation></ref><ref id="bib0075"><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Lee</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>C.K.</given-names></name><name><surname>Jung</surname><given-names>J.K.</given-names></name><name><surname>Han</surname><given-names>S.B.</given-names></name><name><surname>Hong</surname><given-names>J.T.</given-names></name></person-group><article-title>Therapeutic applications of compounds in the Magnolia family</article-title><source>Pharmacology &#x00026; Therapeutics</source><volume>130</volume><issue>2</issue><year>2011</year><fpage>157</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.01.010</pub-id><pub-id pub-id-type="pmid">21277893</pub-id></element-citation></ref><ref id="bib0076"><element-citation publication-type="journal" id="sbref0076"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Casteels</surname><given-names>T.</given-names></name><name><surname>Frogne</surname><given-names>T.</given-names></name><name><surname>Ingvorsen</surname><given-names>C.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>C.</given-names></name><name><surname>Courtney</surname><given-names>M.</given-names></name><name><surname>Huber</surname><given-names>K.V.M.</given-names></name><name><surname>Schmitner</surname><given-names>N.</given-names></name><name><surname>Kimmel</surname><given-names>R.A.</given-names></name><name><surname>Romanov</surname><given-names>R.A.</given-names></name><name><surname>Sturtzel</surname><given-names>C.</given-names></name><name><surname>Lardeau</surname><given-names>C.H.</given-names></name><name><surname>Klughammer</surname><given-names>J.</given-names></name><name><surname>Farlik</surname><given-names>M.</given-names></name><name><surname>Sdelci</surname><given-names>S.</given-names></name><name><surname>Vieira</surname><given-names>A.</given-names></name><name><surname>Avolio</surname><given-names>F.</given-names></name><name><surname>Briand</surname><given-names>F.</given-names></name><name><surname>Baburin</surname><given-names>I.</given-names></name><name><surname>M&#x000e1;jek</surname><given-names>P.</given-names></name><name><surname>Pauler</surname><given-names>F.M.</given-names></name><name><surname>Penz</surname><given-names>T.</given-names></name><name><surname>Stukalov</surname><given-names>A.</given-names></name><name><surname>Gridling</surname><given-names>M.</given-names></name><name><surname>Parapatics</surname><given-names>K.</given-names></name><name><surname>Barbieux</surname><given-names>C.</given-names></name><name><surname>Berishvili</surname><given-names>E.</given-names></name><name><surname>Spittler</surname><given-names>A.</given-names></name><name><surname>Colinge</surname><given-names>J.</given-names></name><name><surname>Bennett</surname><given-names>K.L.</given-names></name><name><surname>Hering</surname><given-names>S.</given-names></name><name><surname>Sulpice</surname><given-names>T.</given-names></name><name><surname>Bock</surname><given-names>C.</given-names></name><name><surname>Distel</surname><given-names>M.</given-names></name><name><surname>Harkany</surname><given-names>T.</given-names></name><name><surname>Meyer</surname><given-names>D.</given-names></name><name><surname>Superti-Furga</surname><given-names>G.</given-names></name><name><surname>Collombat</surname><given-names>P.</given-names></name><name><surname>Hecksher-S&#x000f8;rensen</surname><given-names>J.</given-names></name><name><surname>Kubicek</surname><given-names>S.</given-names></name></person-group><article-title>Artemisinins target GABA a receptor signaling and impair &#x003b1; cell identity</article-title><source>Cell</source><volume>168</volume><issue>1&#x02013;2</issue><year>2017</year><fpage>86</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.010</pub-id><comment>e15https://doi.org/</comment><pub-id pub-id-type="pmid">27916275</pub-id></element-citation></ref><ref id="bib0077"><element-citation publication-type="journal" id="sbref0077"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.S.</given-names></name><name><surname>Jin</surname><given-names>S.E.</given-names></name><name><surname>Kim</surname><given-names>O.S.</given-names></name><name><surname>Shin</surname><given-names>H.K.</given-names></name><name><surname>Jeong</surname><given-names>S.J.</given-names></name></person-group><article-title>Alantolactone from <italic>Saussurea lappa</italic> exerts antiinflammatory effects by inhibiting chemokine production and STAT1 phosphorylation in TNF&#x02010;&#x003b1; and IFN&#x02010;&#x003b3;&#x02010;induced in HaCaT cells</article-title><source>Phytotherapy Research</source><volume>29</volume><issue>7</issue><year>2015</year><fpage>1088</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1002/ptr.5354</pub-id><pub-id pub-id-type="pmid">25881570</pub-id></element-citation></ref><ref id="bib0078"><element-citation publication-type="book" id="sbref0078"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>T.K.</given-names></name></person-group><chapter-title>Helianthus annuus</chapter-title><person-group person-group-type="editor"><name><surname>Lim</surname><given-names>T.K</given-names></name></person-group><source>Edible Medicinal And Non-Medicinal Plants</source><year>2014</year><publisher-name>Springer</publisher-name><publisher-loc>Dordrecht</publisher-loc><fpage>372</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-7395-0_24</pub-id></element-citation></ref><ref id="bib0079"><element-citation publication-type="journal" id="sbref0079"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.R.</given-names></name></person-group><article-title>Sesquiterpene lactones from <italic>Tithonia diversifolia</italic> act as peroxisome proliferator-activated receptor agonists</article-title><source>Bioorganic &#x00026; Medicinal Chemistry Letters</source><volume>22</volume><issue>8</issue><year>2012</year><fpage>2954</fpage><lpage>2958</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2012.02.043</pub-id><pub-id pub-id-type="pmid">22424975</pub-id></element-citation></ref><ref id="bib0080"><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Gong</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Yin</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>F.</given-names></name><name><surname>Long</surname><given-names>H.</given-names></name></person-group><article-title>Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice</article-title><source>Pharmacological Research</source><volume>150</volume><year>2019</year><object-id pub-id-type="publisher-id">104506</object-id><pub-id pub-id-type="doi">10.1016/j.phrs.2019.104506</pub-id></element-citation></ref><ref id="bib0081"><element-citation publication-type="journal" id="sbref0081"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>M.</given-names></name><name><surname>Zatterale</surname><given-names>F.</given-names></name><name><surname>Naderi</surname><given-names>J.</given-names></name><name><surname>Parrillo</surname><given-names>L.</given-names></name><name><surname>Formisano</surname><given-names>P.</given-names></name><name><surname>Raciti</surname><given-names>G.A.</given-names></name><name><surname>Beguinot</surname><given-names>F.</given-names></name><name><surname>Miele</surname><given-names>C.</given-names></name></person-group><article-title>Adipose tissue dysfunction as determinant of obesity-associated metabolic complications</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><issue>9</issue><year>2019</year><fpage>2358</fpage><pub-id pub-id-type="doi">10.3390/ijms20092358</pub-id></element-citation></ref><ref id="bib0082"><element-citation publication-type="journal" id="sbref0082"><person-group person-group-type="author"><name><surname>Ly&#x000df;</surname><given-names>G.</given-names></name><name><surname>Knorre</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>T.J.</given-names></name><name><surname>Pahl</surname><given-names>H.L.</given-names></name><name><surname>Merfort</surname><given-names>I.</given-names></name></person-group><article-title>The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-&#x003ba;B by directly targeting p65</article-title><source>Journal of Biological Chemistry</source><volume>273</volume><issue>50</issue><year>1998</year><fpage>33508</fpage><lpage>33516</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.50.33508</pub-id></element-citation></ref><ref id="bib0083"><element-citation publication-type="journal" id="sbref0083"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>G.</given-names></name><name><surname>Khan</surname><given-names>S.I.</given-names></name><name><surname>Benavides</surname><given-names>G.</given-names></name><name><surname>Sch&#x000fc;hly</surname><given-names>W.</given-names></name><name><surname>Fischer</surname><given-names>N.H.</given-names></name><name><surname>Khan</surname><given-names>I.A.</given-names></name><name><surname>Pasco</surname><given-names>D.S.</given-names></name></person-group><article-title>Inhibition of NF-&#x003ba;B-mediated transcription and induction of apoptosis by melampolides and repandolides</article-title><source>Cancer Chemotherapy and Pharmacology</source><volume>60</volume><issue>1</issue><year>2007</year><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/s00280-006-0344-0</pub-id><pub-id pub-id-type="pmid">17149609</pub-id></element-citation></ref><ref id="bib0084"><element-citation publication-type="book" id="sbref0084"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>M.J.A.</given-names></name><name><surname>Del Olmo</surname><given-names>L.M.B.</given-names></name><name><surname>Ticona</surname><given-names>L.A.</given-names></name><name><surname>Benito</surname><given-names>P.B.</given-names></name></person-group><chapter-title>The <italic>Artemisia</italic> L. genus: a review of bioactive sesquiterpene lactones</chapter-title><person-group person-group-type="editor"><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group><series>Studies in Natural Products Chemistry</series><volume>37</volume><year>2012</year><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam</publisher-loc><fpage>43</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-59514-0.00002-X</pub-id></element-citation></ref><ref id="bib0085"><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Merfort</surname><given-names>I.</given-names></name></person-group><article-title>Perspectives on sesquiterpene lactones in inflammation and cancer</article-title><source>Current Drug Targets</source><volume>12</volume><issue>11</issue><year>2011</year><fpage>1560</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.2174/138945011798109437</pub-id><pub-id pub-id-type="pmid">21561425</pub-id></element-citation></ref><ref id="bib0086"><element-citation publication-type="journal" id="sbref0086"><person-group person-group-type="author"><name><surname>Michalska</surname><given-names>K.</given-names></name><name><surname>Szneler</surname><given-names>E.</given-names></name><name><surname>Kisiel</surname><given-names>W.</given-names></name></person-group><article-title>Sesquiterpene lactones from <italic>Lactuca canadensis</italic> and their chemotaxonomic significance</article-title><source>Phytochemistry</source><volume>90</volume><year>2013</year><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2013.02.005</pub-id><pub-id pub-id-type="pmid">23522933</pub-id></element-citation></ref><ref id="bib0087"><element-citation publication-type="journal" id="sbref0087"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>T.</given-names></name><name><surname>Itoh</surname><given-names>Y.</given-names></name><name><surname>Ishida</surname><given-names>T.</given-names></name></person-group><article-title>Hypoglycemic and hypolipidemic activity of the leaf of <italic>Samallanthus sonchifolius</italic> in genetically type 2 diabetic mice</article-title><source>Journal of Traditional Medicines</source><volume>21</volume><issue>6</issue><year>2004</year><fpage>275</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.11339/jtm.21.275</pub-id></element-citation></ref><ref id="bib0088"><element-citation publication-type="journal" id="sbref0088"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>A.E.H.H.</given-names></name><name><surname>El-Sayed</surname><given-names>M.A.</given-names></name><name><surname>Hegazy</surname><given-names>M.E.</given-names></name><name><surname>Helaly</surname><given-names>S.E.</given-names></name><name><surname>Esmail</surname><given-names>A.M.</given-names></name><name><surname>Mohamed</surname><given-names>N.S.</given-names></name></person-group><article-title>Chemical constituents and biological activities of <italic>Artemisia herba-alba</italic></article-title><source>Records of Natural Products</source><volume>4</volume><issue>1</issue><year>2010</year><fpage>1</fpage><lpage>25</lpage><ext-link ext-link-type="uri" xlink:href="http://www.acgpubs.org/article/records-of-natural-products/2010/1-january-march/chemical-constituents-and-biological-activities-of-artemisia-herba-alba" id="interref0006">http://www.acgpubs.org/article/records-of-natural-products/2010/1-january-march/chemical-constituents-and-biological-activities-of-artemisia-herba-alba</ext-link></element-citation></ref><ref id="bib0089"><element-citation publication-type="journal" id="sbref0089"><person-group person-group-type="author"><name><surname>Moujir</surname><given-names>L.</given-names></name><name><surname>Callies</surname><given-names>O.</given-names></name><name><surname>Sousa</surname><given-names>P.</given-names></name><name><surname>Sharopov</surname><given-names>F.</given-names></name><name><surname>Seca</surname><given-names>A.M.</given-names></name></person-group><article-title>Applications of sesquiterpene lactones: a review of some potential success cases</article-title><source>Applied Sciences</source><volume>10</volume><issue>9</issue><year>2020</year><fpage>3001</fpage><pub-id pub-id-type="doi">10.3390/app10093001</pub-id></element-citation></ref><ref id="bib0090"><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Nicolle</surname><given-names>C.</given-names></name><name><surname>Cardinault</surname><given-names>N.</given-names></name><name><surname>Gueux</surname><given-names>E.</given-names></name><name><surname>Jaffrelo</surname><given-names>L.</given-names></name><name><surname>Rock</surname><given-names>E.</given-names></name><name><surname>Mazur</surname><given-names>A.</given-names></name><name><surname>Amouroux</surname><given-names>P.</given-names></name><name><surname>R&#x000e9;m&#x000e9;sy</surname><given-names>C.</given-names></name></person-group><article-title>Health effect of vegetable-based diet: Lettuce consumption improves cholesterol metabolism and antioxidant status in the rat</article-title><source>Clinical Nutrition</source><volume>23</volume><issue>4</issue><year>2004</year><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2003.10.009</pub-id><pub-id pub-id-type="pmid">15297097</pub-id></element-citation></ref><ref id="bib0091"><element-citation publication-type="journal" id="sbref0091"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>M.</given-names></name><name><surname>Cordell</surname><given-names>G.A.</given-names></name><name><surname>Farnsworth</surname><given-names>N.R.</given-names></name></person-group><article-title>Anticancer sesquiterpene lactones of <italic>Michelia compressa</italic> (magnoliaceae)</article-title><source>Phytochemistry</source><volume>17</volume><issue>5</issue><year>1978</year><fpage>957</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)88656-2</pub-id></element-citation></ref><ref id="bib0092"><element-citation publication-type="journal" id="sbref0092"><person-group person-group-type="author"><name><surname>Onoja</surname><given-names>S.O.</given-names></name><name><surname>Anaga</surname><given-names>A.O.</given-names></name></person-group><article-title>Evaluation of the antidiabetic and antioxidant potentials of methanolic leaf extract of <italic>Helianthus annuus</italic> L. on alloxan-induced hyperglycemic rats</article-title><source>Comparative Clinical Pathology</source><volume>23</volume><issue>5</issue><year>2014</year><fpage>1565</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1007/s00580-013-1824-3</pub-id></element-citation></ref><ref id="bib0093"><element-citation publication-type="journal" id="sbref0093"><person-group person-group-type="author"><name><surname>Onoja</surname><given-names>S.O.</given-names></name><name><surname>Nnadi</surname><given-names>C.O.</given-names></name><name><surname>Udem</surname><given-names>S.C.</given-names></name><name><surname>Anaga</surname><given-names>A.O.</given-names></name></person-group><article-title>Potential antidiabetic and antioxidant activities of a heliangolide sesquiterpene lactone isolated from <italic>Helianthus annuus</italic> L. leaves</article-title><source>Acta Pharmaceutica</source><volume>70</volume><issue>2</issue><year>2020</year><fpage>215</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.2478/acph-2020-0019</pub-id><pub-id pub-id-type="pmid">31955145</pub-id></element-citation></ref><ref id="bib0094"><element-citation publication-type="journal" id="sbref0094"><person-group person-group-type="author"><name><surname>Onoja</surname><given-names>S.O.</given-names></name><name><surname>Udem</surname><given-names>S.C.</given-names></name><name><surname>Anaga</surname><given-names>A.O.</given-names></name></person-group><article-title>Hypoglycemic, antidyslipidemic, hepatoprotective and antilipid peroxidation activities of hydromethanol leaf extract of <italic>Helianthus annuus</italic> in alloxan-induced diabetic rats</article-title><source>Tropical Journal of Pharmaceutical Research</source><volume>17</volume><issue>9</issue><year>2018</year><fpage>1817</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.4314/tjpr.v17i9.20</pub-id></element-citation></ref><ref id="bib0095"><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>N.</given-names></name><name><surname>G&#x000f6;kbulut</surname><given-names>A.</given-names></name><name><surname>Orhan</surname><given-names>D.D.</given-names></name></person-group><article-title>Antioxidant potential and carbohydrate digestive enzyme inhibitory effects of five <italic>Inula</italic> species and their major compounds</article-title><source>South African Journal of Botany</source><volume>111</volume><year>2017</year><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2017.03.040</pub-id></element-citation></ref><ref id="bib0096"><element-citation publication-type="journal" id="sbref0096"><person-group person-group-type="author"><name><surname>Padilla-Gonzalez</surname><given-names>G.F.</given-names></name><name><surname>dos Santos</surname><given-names>F.A.</given-names></name><name><surname>Da Costa</surname><given-names>F.B.</given-names></name></person-group><article-title>Sesquiterpene lactones: more than protective plant compounds with high toxicity</article-title><source>Critical Reviews in Plant Sciences</source><volume>35</volume><issue>1</issue><year>2016</year><fpage>18</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1080/07352689.2016.1145956</pub-id></element-citation></ref><ref id="bib0097"><element-citation publication-type="journal" id="sbref0097"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>M.</given-names></name><name><surname>Febbraio</surname><given-names>M.A.</given-names></name><name><surname>Lancaster</surname><given-names>G.I.</given-names></name></person-group><article-title>The roles of c&#x02010;Jun NH2&#x02010;terminal kinases (JNKs) in obesity and insulin resistance</article-title><source>The Journal of Physiology</source><volume>594</volume><issue>2</issue><year>2016</year><fpage>267</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1113/JP271457</pub-id><pub-id pub-id-type="pmid">26608096</pub-id></element-citation></ref><ref id="bib0098"><element-citation publication-type="journal" id="sbref0098"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.H.</given-names></name><name><surname>Kim</surname><given-names>M.J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>Y.N.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Kim</surname><given-names>S.G.</given-names></name><name><surname>Park</surname><given-names>H.J.</given-names></name><name><surname>Son</surname><given-names>J.K.</given-names></name><name><surname>Chang</surname><given-names>H.W.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name></person-group><article-title>Britanin suppresses LPS-induced nitric oxide, PGE2 and cytokine production via NF-&#x003ba;B and MAPK inactivation in RAW 264.7 cells</article-title><source>International Immunopharmacology</source><volume>15</volume><issue>2</issue><year>2013</year><fpage>296</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2012.12.005</pub-id><pub-id pub-id-type="pmid">23270759</pub-id></element-citation></ref><ref id="bib0099"><element-citation publication-type="journal" id="sbref0099"><person-group person-group-type="author"><name><surname>Perez-Gutierrez</surname><given-names>R.M.</given-names></name><name><surname>Mu&#x000f1;iz-Ramirez</surname><given-names>A.</given-names></name><name><surname>Gomez</surname><given-names>Y.G.</given-names></name><name><surname>Ram&#x000ed;rez</surname><given-names>E.B.</given-names></name></person-group><article-title>Antihyperglycemic, antihyperlipidemic and antiglycation effects of <italic>Byrsonima crassifolia</italic> fruit and seed in normal and streptozotocin-induced diabetic rats</article-title><source>Plant Foods for Human Nutrition</source><volume>65</volume><issue>4</issue><year>2010</year><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1007/s11130-010-0181-5</pub-id><pub-id pub-id-type="pmid">20734144</pub-id></element-citation></ref><ref id="bib0100"><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Pushparaj</surname><given-names>P.N.</given-names></name><name><surname>Low</surname><given-names>H.K.</given-names></name><name><surname>Manikandan</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>B.K.H.</given-names></name><name><surname>Tan</surname><given-names>C.H.</given-names></name></person-group><article-title>Anti-diabetic effects of <italic>Cichorium intybus</italic> in streptozotocin-induced diabetic rats</article-title><source>Journal of Ethnopharmacology</source><volume>111</volume><issue>2</issue><year>2007</year><fpage>430</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.11.028</pub-id><pub-id pub-id-type="pmid">17197141</pub-id></element-citation></ref><ref id="bib0101"><element-citation publication-type="journal" id="sbref0101"><person-group person-group-type="author"><name><surname>R&#x000e0;fols</surname><given-names>M.E.</given-names></name></person-group><article-title>Adipose tissue: cell heterogeneity and functional diversity</article-title><source>Endocrinolog&#x000ed;a y Nutrici&#x000f3;n (English Edition)</source><volume>61</volume><issue>2</issue><year>2014</year><fpage>100</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.endoen.2014.02.001</pub-id></element-citation></ref><ref id="bib0102"><element-citation publication-type="journal" id="sbref0102"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Kinghorn</surname><given-names>A.D.</given-names></name></person-group><article-title>Development of anticancer agents from plant-derived sesquiterpene lactones</article-title><source>Current Medicinal Chemistry</source><volume>23</volume><issue>23</issue><year>2016</year><fpage>2397</fpage><lpage>2420</lpage><pub-id pub-id-type="doi">10.2174/0929867323666160510123255</pub-id><pub-id pub-id-type="pmid">27160533</pub-id></element-citation></ref><ref id="bib0103"><element-citation publication-type="journal" id="sbref0103"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>A.J.</given-names></name><name><surname>Fuller</surname><given-names>S.</given-names></name><name><surname>Fedorcenco</surname><given-names>V.</given-names></name><name><surname>Beyl</surname><given-names>R.</given-names></name><name><surname>Burris</surname><given-names>T.P.</given-names></name><name><surname>Mynatt</surname><given-names>R.</given-names></name><name><surname>Ribnicky</surname><given-names>D.M.</given-names></name><name><surname>Stephens</surname><given-names>J.M.</given-names></name></person-group><article-title><italic>Artemisia scoparia</italic> enhances adipocyte development and endocrine function <italic>in vitro</italic> and enhances insulin action <italic>in vivo</italic></article-title><source>PLoS One</source><volume>9</volume><issue>6</issue><year>2014</year><fpage>e98897</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0098897</pub-id><pub-id pub-id-type="pmid">24915004</pub-id></element-citation></ref><ref id="bib0104"><element-citation publication-type="journal" id="sbref0104"><person-group person-group-type="author"><name><surname>Rogero</surname><given-names>M.M.</given-names></name><name><surname>Calder</surname><given-names>P.C.</given-names></name></person-group><article-title>Obesity, inflammation, toll-like receptor 4 and fatty acids</article-title><source>Nutrients</source><volume>10</volume><issue>4</issue><year>2018</year><fpage>432</fpage><pub-id pub-id-type="doi">10.3390/nu10040432</pub-id></element-citation></ref><ref id="bib0105"><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>C.H.</given-names></name><name><surname>So</surname><given-names>S.P.</given-names></name><name><surname>Ruan</surname><given-names>K.H.</given-names></name></person-group><article-title>Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart disease</article-title><source>Life Sciences</source><volume>88</volume><year>2011</year><fpage>24</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2010.10.017</pub-id><pub-id pub-id-type="pmid">21035466</pub-id></element-citation></ref><ref id="bib0106"><element-citation publication-type="journal" id="sbref0106"><person-group person-group-type="author"><name><surname>Salih</surname><given-names>B.A.</given-names></name></person-group><article-title>Effect of <italic>Lactuca serriola</italic> on &#x003b2;-Cell dysfunction and glucose tolerance induced by high sucrose fed in albino rats</article-title><source>Journal of Physics: Conference Series</source><volume>1294</volume><issue>6</issue><year>2019</year><fpage>0</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1088/1742-6596/1294/6/062092</pub-id></element-citation></ref><ref id="bib0107"><element-citation publication-type="book" id="sbref0107"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>T.J.</given-names></name></person-group><chapter-title>Structure-activity relationships of sesquiterpene lactones</chapter-title><person-group person-group-type="editor"><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group><series>Studies in Natural Products Chemistry</series><volume>33</volume><year>2006</year><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam</publisher-loc><fpage>309</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/S1572-5995(06)80030-X</pub-id><comment>Part Mhttps://doi.org/</comment></element-citation></ref><ref id="bib0108"><element-citation publication-type="journal" id="sbref0108"><person-group person-group-type="author"><name><surname>Schorr</surname><given-names>K.</given-names></name><name><surname>Merfort</surname><given-names>I.</given-names></name><name><surname>Da Costa</surname><given-names>F.B.</given-names></name></person-group><article-title>A novel dimeric melampolide and further terpenoids from <italic>Smallanthus sonchifolius</italic> (Asteraceae) and the inhibition of the transcription factor NF-&#x003ba;B</article-title><source>Natural Product Communications</source><volume>2</volume><issue>4</issue><year>2007</year><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1177/1934578X0700200404</pub-id></element-citation></ref><ref id="bib0109"><element-citation publication-type="journal" id="sbref0109"><person-group person-group-type="author"><name><surname>Seca</surname><given-names>A.M.L.</given-names></name><name><surname>Grigore</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>D.C.G.A.</given-names></name><name><surname>Silva</surname><given-names>A.M.S.</given-names></name></person-group><article-title>The genus <italic>Inula</italic> and their metabolites: From ethnopharmacological to medicinal uses</article-title><source>Journal of Ethnopharmacology</source><volume>154</volume><issue>2</issue><year>2014</year><fpage>286</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.04.010</pub-id><pub-id pub-id-type="pmid">24754913</pub-id></element-citation></ref><ref id="bib0110"><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>B.C.</given-names></name><name><surname>Cabrera</surname><given-names>W.M.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.M.</given-names></name><name><surname>Mercado</surname><given-names>M.I.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>A.S.</given-names></name><name><surname>Genta</surname><given-names>S.B.</given-names></name></person-group><article-title>Safety assessment of aqueous extract from leaf <italic>Smallanthus sonchifolius</italic> and its main active lactone, enhydrin</article-title><source>Journal of Ethnopharmacology</source><volume>144</volume><issue>2</issue><year>2012</year><fpage>362</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.09.02</pub-id><pub-id pub-id-type="pmid">23000115</pub-id></element-citation></ref><ref id="bib0111"><element-citation publication-type="journal" id="sbref0111"><person-group person-group-type="author"><name><surname>Serra-Barcellona</surname><given-names>C.</given-names></name><name><surname>Ar&#x000e1;oz</surname><given-names>M.V.C.</given-names></name><name><surname>Cabrera</surname><given-names>W.M.</given-names></name><name><surname>Habib</surname><given-names>N.C.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.M.</given-names></name><name><surname>Catal&#x000e1;n</surname><given-names>C.A.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>S.S.</given-names></name></person-group><article-title><italic>Smallanthus macroscyphus</italic>: a new source of antidiabetic compounds</article-title><source>Chemico-Biological Interactions</source><volume>209</volume><year>2014</year><fpage>35</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2013.11.015</pub-id><pub-id pub-id-type="pmid">24309157</pub-id></element-citation></ref><ref id="bib0112"><element-citation publication-type="journal" id="sbref0112"><person-group person-group-type="author"><name><surname>Serra-Barcellona</surname><given-names>C.</given-names></name><name><surname>Habib</surname><given-names>N.C.</given-names></name><name><surname>Honore</surname><given-names>S.M.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>S.S.</given-names></name><name><surname>Genta</surname><given-names>S.B.</given-names></name></person-group><article-title>Enhydrin regulates postprandial hyperglycemia in diabetic rats by inhibition of &#x003b1;-glucosidase activity</article-title><source>Plant Foods for Human Nutrition</source><volume>72</volume><issue>2</issue><year>2017</year><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1007/s11130-017-0600-y</pub-id><pub-id pub-id-type="pmid">28161878</pub-id></element-citation></ref><ref id="bib0113"><element-citation publication-type="journal" id="sbref0113"><person-group person-group-type="author"><name><surname>Serra-Barcellona</surname><given-names>C.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>S.M.</given-names></name><name><surname>Cabrera</surname><given-names>W.M.</given-names></name><name><surname>Habib</surname><given-names>N.C.</given-names></name><name><surname>Genta</surname><given-names>S.B.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>S.S.</given-names></name></person-group><article-title>Polymatin A from <italic>Smallanthus macroscyphus</italic> leaves: A safe and promising antidiabetic compound</article-title><source>Journal of Applied Toxicology</source><volume>36</volume><year>2016</year><fpage>1516</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1002/jat.3312</pub-id><pub-id pub-id-type="pmid">27062070</pub-id></element-citation></ref><ref id="bib0114"><element-citation publication-type="journal" id="sbref0114"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>J.J.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Ren</surname><given-names>J.W.</given-names></name></person-group><article-title>Anti-diabetic and hypolipidemic effects of aqueous-extract from the flower of <italic>Inula japonica</italic> in alloxan-induced diabetic mice</article-title><source>Biological and Pharmaceutical Bulletin</source><volume>29</volume><issue>3</issue><year>2006</year><fpage>455</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.455</pub-id><pub-id pub-id-type="pmid">16508145</pub-id></element-citation></ref><ref id="bib0115"><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Simelane</surname><given-names>D.O.</given-names></name><name><surname>Mawela</surname><given-names>K.V.</given-names></name><name><surname>Fourie</surname><given-names>A.</given-names></name></person-group><article-title>Prospective agents for the biological control of <italic>Tithonia rotundifolia</italic> (Mill.) S.F. Blake and <italic>Tithonia diversifolia</italic> (Hemsl.) A. Gray (Asteraceae) in South Africa</article-title><source>African Entomology</source><volume>19</volume><issue>2</issue><year>2011</year><fpage>443</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.4001/003.019.0223</pub-id></element-citation></ref><ref id="bib0116"><element-citation publication-type="book" id="sbref0116"><person-group person-group-type="author"><name><surname>Simonsen</surname><given-names>H.T.</given-names></name><name><surname>Weitzel</surname><given-names>C.</given-names></name><name><surname>Christensen</surname><given-names>S.B.</given-names></name></person-group><chapter-title>Guaianolide sesquiterpenoids: pharmacology and biosynthesis</chapter-title><person-group person-group-type="editor"><name><surname>Ramawat</surname><given-names>K.</given-names></name><name><surname>M&#x000e9;rillon</surname><given-names>J.M.</given-names></name></person-group><source>Natural Products</source><year>2013</year><publisher-name>Springer</publisher-name><publisher-loc>Berlin, Heidelberg</publisher-loc><fpage>3069</fpage><lpage>3098</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-22144-6_134</pub-id></element-citation></ref><ref id="bib0117"><element-citation publication-type="journal" id="sbref0117"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N.P.</given-names></name><name><surname>Lai</surname><given-names>H.C.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Gerhardt</surname><given-names>T.E.</given-names></name><name><surname>Kim</surname><given-names>B.J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group><article-title>Effects of artemisinin dimers on rat breast cancer cells <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Anticancer Research</source><volume>31</volume><issue>12</issue><year>2011</year><fpage>4111</fpage><lpage>4114</lpage><ext-link ext-link-type="uri" xlink:href="http://ar.iiarjournals.org/content/31/12/4111.short" id="interref0007">http://ar.iiarjournals.org/content/31/12/4111.short</ext-link><pub-id pub-id-type="pmid">22199268</pub-id></element-citation></ref><ref id="bib0118"><element-citation publication-type="journal" id="sbref0118"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>S.</given-names></name><name><surname>Pinto</surname><given-names>J.</given-names></name><name><surname>Rodrigues</surname><given-names>C.</given-names></name><name><surname>Gi&#x000e3;o</surname><given-names>M.</given-names></name><name><surname>Pereira</surname><given-names>C.</given-names></name><name><surname>Tavaria</surname><given-names>F.</given-names></name><name><surname>Pintado</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant properties of sterilized yacon (<italic>Smallanthus sonchifolius)</italic> tuber flour</article-title><source>Food Chemistry</source><volume>188</volume><year>2015</year><fpage>504</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2015.04.047</pub-id><pub-id pub-id-type="pmid">26041224</pub-id></element-citation></ref><ref id="bib0119"><element-citation publication-type="book" id="sbref0119"><person-group person-group-type="author"><name><surname>Subramoniam</surname><given-names>A.</given-names></name></person-group><chapter-title>Plants With Anti-Diabetes Mellitus Properties</chapter-title><year>2016</year><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton</publisher-loc><fpage>17</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1201/9781315371481</pub-id></element-citation></ref><ref id="bib0120"><element-citation publication-type="book" id="sbref0120"><person-group person-group-type="author"><name><surname>S&#x000fc;lsen</surname><given-names>V.P.</given-names></name><name><surname>Catal&#x000e1;n</surname><given-names>C.A.N.</given-names></name><name><surname>Martino</surname><given-names>V.S.</given-names></name></person-group><chapter-title>Analytical procedures</chapter-title><person-group person-group-type="editor"><name><surname>S&#x000fc;lsen</surname><given-names>V.P.</given-names></name><name><surname>Martino</surname><given-names>V.S.</given-names></name></person-group><source>Sesquiterpene Lactones: Advances in Their Chemistry and Biological Aspects</source><year>2018</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><fpage>119</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-78274-4_6</pub-id></element-citation></ref><ref id="bib0121"><element-citation publication-type="book" id="sbref0121"><person-group person-group-type="author"><name><surname>S&#x000fc;lsen</surname><given-names>V.P.</given-names></name><name><surname>Martino</surname><given-names>V.S.</given-names></name></person-group><chapter-title>Overview</chapter-title><person-group person-group-type="editor"><name><surname>S&#x000fc;lsen</surname><given-names>V.P.</given-names></name><name><surname>Martino</surname><given-names>V.S.</given-names></name></person-group><source>Sesquiterpene Lactones: Advances in Their Chemistry and Biological Aspects</source><year>2018</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><fpage>3</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-78274-4_1</pub-id></element-citation></ref><ref id="bib0122"><element-citation publication-type="journal" id="sbref0122"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Fu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xing</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name></person-group><article-title><italic>Magnolia officinalis</italic> extract contains potent inhibitors against PTP1B and attenuates hyperglycemia in db/db mice</article-title><source>BioMed Research International</source><year>2015</year><object-id pub-id-type="publisher-id">139451</object-id><pub-id pub-id-type="doi">10.1155/2015/139451</pub-id></element-citation></ref><ref id="bib0123"><element-citation publication-type="journal" id="sbref0123"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Tong</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Micheliolide suppresses LPS-induced neuroinflammatory responses</article-title><source>PLoS One</source><volume>12</volume><issue>10</issue><year>2017</year><object-id pub-id-type="publisher-id">e0186592</object-id><pub-id pub-id-type="doi">10.1371/journal.pone.0186592</pub-id></element-citation></ref><ref id="bib0124"><element-citation publication-type="journal" id="sbref0124"><person-group person-group-type="author"><name><surname>Tagne</surname><given-names>A.M.</given-names></name><name><surname>Marino</surname><given-names>F.</given-names></name><name><surname>Cosentino</surname><given-names>M.</given-names></name></person-group><article-title><italic>Tithonia diversifolia</italic> (Hemsl.) A. Gray as a medicinal plant: a comprehensive review of its ethnopharmacology, phytochemistry, pharmacotoxicology and clinical relevance</article-title><source>Journal of Ethnopharmacology</source><volume>220</volume><year>2018</year><fpage>94</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.03.025</pub-id><pub-id pub-id-type="pmid">29596999</pub-id></element-citation></ref><ref id="bib0125"><element-citation publication-type="book" id="sbref0125"><person-group person-group-type="author"><name><surname>Tisserand</surname><given-names>R.</given-names></name><name><surname>Young</surname><given-names>R.</given-names></name></person-group><chapter-title>Essential Oil Safety. A Guide for Health Care Professionals</chapter-title><edition>second ed.</edition><year>2014</year><publisher-name>Elsevier Health Sciences</publisher-name><publisher-loc>China</publisher-loc></element-citation></ref><ref id="bib0126"><element-citation publication-type="journal" id="sbref0126"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>Y.</given-names></name></person-group><article-title>Artemisinin&#x02014;A gift from Traditional Chinese Medicine to the world (Nobel Lecture)</article-title><source>Angewandte Chemie International Edition</source><volume>55</volume><year>2016</year><fpage>10210</fpage><lpage>10226</lpage><pub-id pub-id-type="doi">10.1002/anie.201601967</pub-id><pub-id pub-id-type="pmid">27488942</pub-id></element-citation></ref><ref id="bib0127"><element-citation publication-type="journal" id="sbref0127"><person-group person-group-type="author"><name><surname>Viennois</surname><given-names>E.</given-names></name><name><surname>Xiao</surname><given-names>B.</given-names></name><name><surname>Ayyadurai</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>P.G.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Merlin</surname><given-names>D.</given-names></name></person-group><article-title>Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer</article-title><source>Laboratory Investigation</source><volume>94</volume><issue>9</issue><year>2014</year><fpage>950</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2014.89</pub-id><pub-id pub-id-type="pmid">25068660</pub-id></element-citation></ref><ref id="bib0128"><element-citation publication-type="journal" id="sbref0128"><person-group person-group-type="author"><name><surname>Waisundara</surname><given-names>V.Y.</given-names></name><name><surname>Watawana</surname><given-names>M.I.</given-names></name><name><surname>Jayawardena</surname><given-names>N.</given-names></name></person-group><article-title><italic>Costus speciosus</italic> and <italic>Coccinia grandis</italic>: Traditional medicinal remedies for diabetes</article-title><source>South African Journal of Botany</source><volume>98</volume><year>2015</year><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2015.01.012</pub-id></element-citation></ref><ref id="bib0129"><element-citation publication-type="journal" id="sbref0129"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Shan</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title><italic>Inula</italic> sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity</article-title><source>Expert Opinion on Investigational Drugs</source><volume>23</volume><issue>3</issue><year>2014</year><fpage>317</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1517/13543784.2014.868882</pub-id><pub-id pub-id-type="pmid">24387187</pub-id></element-citation></ref><ref id="bib0130"><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.Q.</given-names></name><name><surname>Zhang</surname><given-names>X.H.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Tipton</surname><given-names>R.C.</given-names></name><name><surname>Raskin</surname><given-names>I.</given-names></name><name><surname>Ribnicky</surname><given-names>D.</given-names></name><name><surname>Johnson</surname><given-names>W.</given-names></name><name><surname>Cefalu</surname><given-names>W.T.</given-names></name></person-group><article-title><italic>Artemisia scoparia</italic> extract attenuates nonalcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway</article-title><source>Metabolism</source><volume>62</volume><issue>9</issue><year>2013</year><fpage>1239</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2013.03.004</pub-id><comment>2013https://doi.org/</comment><pub-id pub-id-type="pmid">23702383</pub-id></element-citation></ref><ref id="bib0131"><element-citation publication-type="journal" id="sbref0131"><person-group person-group-type="author"><name><surname>Widen</surname><given-names>J.C.</given-names></name><name><surname>Kempema</surname><given-names>A.M.</given-names></name><name><surname>Villalta</surname><given-names>P.W.</given-names></name><name><surname>Harki</surname><given-names>D.A.</given-names></name></person-group><article-title>Targeting NF-&#x003ba;B p65 with a helenalin inspired bis-electrophile</article-title><source>ACS Chemical Biology</source><volume>12</volume><issue>1</issue><year>2017</year><fpage>102</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b00751</pub-id><pub-id pub-id-type="pmid">28103680</pub-id></element-citation></ref><ref id="bib0132"><element-citation publication-type="journal" id="sbref0132"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Adams</surname><given-names>H.</given-names></name><name><surname>Kubena</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name></person-group><article-title>Etiology of metabolic syndrome and dietary intervention</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><issue>1</issue><year>2019</year><fpage>128</fpage><pub-id pub-id-type="doi">10.3390/ijms20010128</pub-id></element-citation></ref><ref id="bib0133"><element-citation publication-type="journal" id="sbref0133"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Ai</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Bao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Alantolactone suppresses APOC3 expression and alters lipid homeostasis in L02 liver cells</article-title><source>European Journal of Pharmacology</source><volume>828</volume><year>2018</year><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.03.021</pub-id><pub-id pub-id-type="pmid">29555504</pub-id></element-citation></ref><ref id="bib0134"><element-citation publication-type="journal" id="sbref0134"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Feng</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>W.</given-names></name></person-group><article-title>&#x003b1;-Glucosidase inhibitors isolated from medicinal plants</article-title><source>Food Science and Human Wellness</source><volume>3</volume><issue>3-4</issue><year>2014</year><fpage>136</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.fshw.2014.11.003</pub-id></element-citation></ref><ref id="bib0135"><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Yung</surname><given-names>J.H.M.</given-names></name><name><surname>Giacca</surname><given-names>A.</given-names></name></person-group><article-title>Role of c-Jun N-terminal Kinase (JNK) in obesity and type 2 diabetes</article-title><source>Cells</source><volume>9</volume><issue>3</issue><year>2020</year><fpage>706</fpage><pub-id pub-id-type="doi">10.3390/cells9030706</pub-id></element-citation></ref><ref id="bib0136"><element-citation publication-type="journal" id="sbref0136"><person-group person-group-type="author"><name><surname>Zeggwagh</surname><given-names>N.A.</given-names></name><name><surname>Ouahidi</surname><given-names>M.L.</given-names></name><name><surname>Lemhadri</surname><given-names>A.</given-names></name><name><surname>Eddouks</surname><given-names>M.</given-names></name></person-group><article-title>Study of hypoglycaemic and hypolipidemic effects of <italic>Inula viscosa</italic> L. aqueous extract in normal and diabetic rats</article-title><source>Journal of Ethnopharmacology</source><volume>108</volume><issue>2</issue><year>2006</year><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.05.005</pub-id><pub-id pub-id-type="pmid">16787724</pub-id></element-citation></ref><ref id="bib0137"><element-citation publication-type="journal" id="sbref0137"><person-group person-group-type="author"><name><surname>Zeke</surname><given-names>A.</given-names></name><name><surname>Misheva</surname><given-names>M.</given-names></name><name><surname>Rem&#x000e9;nyi</surname><given-names>A.</given-names></name><name><surname>Bogoyevitch</surname><given-names>M.A.</given-names></name></person-group><article-title>JNK signaling: regulation and functions based on complex protein-protein partnerships</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>80</volume><issue>3</issue><year>2016</year><fpage>793</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00043-14</pub-id><pub-id pub-id-type="pmid">27466283</pub-id></element-citation></ref><ref id="bib0138"><element-citation publication-type="journal" id="sbref0138"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>J.D.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.L.</given-names></name><name><surname>Lin</surname><given-names>J.P.</given-names></name><name><surname>Qiu</surname><given-names>C.J.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Biomimetic semisynthesis of arglabin from parthenolide</article-title><source>Journal of Organic Chemistry</source><volume>77</volume><issue>16</issue><year>2012</year><fpage>7103</fpage><lpage>7107</lpage><pub-id pub-id-type="doi">10.1021/jo300888s</pub-id></element-citation></ref><ref id="bib0139"><element-citation publication-type="journal" id="sbref0139"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Xi</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name></person-group><article-title>Three new sesquiterpenes from <italic>Tithonia diversifolia</italic> and their anti-hyperglycemic activity</article-title><source>Fitoterapia</source><volume>83</volume><year>2012</year><fpage>1590</fpage><lpage>1597</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.09.007</pub-id><pub-id pub-id-type="pmid">22986291</pub-id></element-citation></ref><ref id="bib0140"><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Kim</surname><given-names>K.T.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name></person-group><article-title>Extracts of <italic>Magnolia</italic> species-induced prevention of diabetic complications: A brief review</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><issue>10</issue><year>2016</year><pub-id pub-id-type="doi">10.3390/ijms17101629</pub-id></element-citation></ref><ref id="bib0141"><element-citation publication-type="journal" id="sbref0141"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Qing</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.Y.</given-names></name><name><surname>Long</surname><given-names>H.</given-names></name></person-group><article-title>Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-&#x003b3;-mediated NF-&#x0043a;B and AMPK/mTOR signaling</article-title><source>International Immunopharmacology</source><volume>59</volume><year>2018</year><fpage>197</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2018.03.036</pub-id></element-citation></ref><ref id="bib0142"><element-citation publication-type="journal" id="sbref0142"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Ling</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Alantolactone mitigates renal injury induced by diabetes via inhibition of high glucose-mediated inflammatory response and macrophage infiltration</article-title><source>Immunopharmacology and Immunotoxicology</source><volume>42</volume><issue>2</issue><year>2020</year><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1080/08923973.2020.1725039</pub-id><pub-id pub-id-type="pmid">32064988</pub-id></element-citation></ref></ref-list><ack id="ack0001"><title>Acknowledgments</title><p id="para0058">This work was partially supported by the <funding-source id="gs0001"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100007161</institution-id><institution>Secretar&#x000ed;a de Investigaci&#x000f3;n y Posgrado, Instituto Polit&#x000e9;cnico Nacional</institution></institution-wrap></funding-source>. ASG was CONACyT (267721) and IPN-BEIFI fellow. Julio C. Ontiveros thanks CONACyT for funding CONACyT project No. 1069 &#x0201c;C&#x000e1;tedras CONACyT&#x0201d;.</p></ack></back></article>